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There is growing evidence that consumption of a Western diet is a 
risk factor for osteoporosis through excess acid supply; fruits and vegetables 
balance the excess acidity, mostly by providing K-rich, bicarbonate-rich 
foods. Western diets consumed by adults generate ~ 50-100 mEq acid/d; 
therefore, healthy adults consuming such a diet are at risk of chronic, low- 
grade metabolic acidosis, which worsens with age due to kidney function 
decline. Bone buffers the excess acid by delivering cations and it is 
considered that with time, an over-stimulation of this process will lead to the 
dissolution of the bone mineral content and, hence, to reduced bone mass.
Intakes of K, Mg, fruit and vegetables have been associated with a 
higher alkaline status and a subsequent beneficial effect on bone health. Few 
studies have been undertaken in very elderly women (>75 years), whose 
osteoporosis risk is very pertinent.
Our EVANIBUS (EVAluation of Nutrient Intake and Bone UltraSound) 
group developed and validated («=51) a Food Frequency Questionnaire 
(FFQ) for use in a frail, elderly, Swiss population (mean age 80.4yrs SD 
2.99), which showed intakes of key nutrients (energy, fat, carbohydrate, Ca, 
Mg, vitamin C, D and E) to be low in 401 subjects. A study was then 
conducted to assess the Net Endogenous Acid Production (NEAP) estimates 
and bone ultra-sound results in 256 women aged 75 y +). Lower NEAP (P=
0.023) and higher K intake (P=0.033) were significantly correlated to higher 
bone ultra-sound results. High acid load may be an important, additional 
risk factor, which may in turn, be particularly relevant in frail patients who 
already have a high risk of fracture. Our study contributes to knowledge by 
confirming a positive link between dietary alkalinity and bone health indices 
in the very elderly
In a further study to compliment these findings, it has also been shown 
that in Ca sufficiency, an acid, Ca-rich water had no effect on bone 
resorption in a group of 30 young women, whilst an alkaline, bicarbonate- 
rich water led to a significant decrease in both PTH and of serum c- 
telopeptide excretion. Further investigations need to be undertaken to study 
whether these positive effects on bone loss are maintained over long-term 
treatment. Mineral water consumption could be an easy and inexpensive 
way of helping to prevent osteoporosis and therefore be of major interest for 
long term prevention of bone loss.
Emma Wynn performed all the studies and wrote the manuscripts as well as 
the entire present Thesis.
Dr Susan Lanham-New provided permanent scientific supervision
especially for the nutritional aspects.
Dr Marc-Antoine Krieg provided permanent scientific supervision
especially for the QUS aspects.
Dr David Whittamore developed the computer programme for the FFQ.
Professor Peter Burckhardt wrote the research protocols, directed and 
coordinated the studies and supervised the manuscripts.
All laboratory work was performed at the university Hospital of Lausanne 
laboratories.
All the statistics for the EMINOS-2 study were performed by Dr Jean-Marc 
Aeschlimann, Statistician.
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_______ 1. GENERAL IN T R O D U C T IO N ________
Osteoporosis is a skeletal disorder characterised by low bone mass and 
micro-architectural deterioration of bone tissue, leading to bone fragility and 
an increased risk of fracture. To achieve optimum bone health, numerous 
factors are required, such as genetics, health and nutrition. It is common to 
think of bone health in terms of calcium intake only. Calcium is indeed a 
critical component of the skeleton; however, not the only one. Whilst the 
optimum diet for osteoporosis prevention remains unknown, a variety of 
nutrients are important to the aging skeleton, including protein, calcium, 
vitamin K, potassium and micronutrients. There is a growing belief that the 
Western diet may be a risk factor for osteoporosis through excess acid 
supply. Fruit and vegetable intake may balance the excess acidity by 
providing potassium.
Recent epidemiological data estimates that, in Switzerland, one in two 
women and one in five men over the age of 50 years, will suffer from an 
osteoporotic fracture during their lifetime [1-2]. Therefore, it is urgent for 
Swiss public health strategies to reduce the predicted increase in 
osteoporosis within the aging population, by undertaking prevention 
campaigns. It is critically important to determine a public health strategy 
which will optimise bone health throughout the lifecycle. The major 
determining factor for osteoporosis is an individual’s genetic makeup, 
which cannot be modified. It is therefore important to identify modifiable 
risk factors that contribute to bone health and utilise these effectively in 
“prevention messages” to the general public. Nutrition is a modifiable 
factor, which can be altered relatively easily and cheaply.
2. LITERATURE REVIEW
The aims of this literature review are to address:
• Bone physiology
• Osteoporosis
• Nutritional factors influencing bone health
• Nutritional assessment and epidemiology
It is acknowledged that other vitamins and minerals than those discussed 
hereafter are very important to bone health. However, for the purpose of this 
original work, it goes beyond the scope of this literature review and will not be 
discussed.
2.1 Bone physiology
2.1.1 A N A T O M Y  OF B O NE A N D  M A C R O S C O P IC  STRU CTU RE  
The skeleton has several vital functions: 1) to allow locomotion; 2) to protect 
internal organs; 3) to maintain mineral homeostasis, 4) to maintain 
hematopoesis and finally, 5) to provide a shield which protects the internal 
organs and bone marrow. Structurally, the skeleton’s role is to supply a 
framework for locomotion by providing rigid support.
Mechanically, to enable everyday activities, bone needs to be rigid, but not 
brittle, and to resist minor traumas. The slightly deformable mineralised 
collagen structure, consisting of a combination of spongy trabecular bone and 
dense cortical bone, allows this. The skeleton protects the internal organs and 
bone marrow by providing a shield.
Metabolically, bone works as a storehouse and as a homeostatic buffer system. 
The major reservoir function of bone is to supply phosphorous and calcium to 
maintain the serum mineral homeostasis, alongwith other ions, such as sodium
and magnesium. Bone marrow serves as a source of precursors of bone cells. 
In that way, bone is unique, as it is capable of self-renewal and repair. It also 
works as a buffer to deal with excess hydrogen ions [3-5].
The skeleton represents 17% of the body weight [6]. There are two major 
types of bones: Long bones (i.e., femur, humerus, radius, etc.) and flat bones 
(i.e. ilium, skull, etc.). These two types of bone are different not only by their 
overall anatomy, but also by their mechanism of development. They are also 
distinguished by the location in the body: Long bones are found in the 
peripheral skeleton, whereas flat bones are generally located in the central 
skeleton.
The anatomy of long bones shows a cylindrical tube in the centre (diaphysis), 
with wider regions at each end (epiphysis) and a transition area in-between 
(metaphysis) [7] (Fig 1).
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FIG. 1 LONG BONE ANATOM Y
(Taken from www.octc.kctcs.edu/gcaplan/anat/images/Image267.gif)
The external surface of bone is formed by the cortex (or cortical bone or 
compact bone). In the diaphysis, the compact bone surrounds the medullary 
marrow cavity, where haematopoietic bone marrow is located. Towards the 
metaphysis and epiphysis, the compact bone becomes thinner while 
surrounding a network of calcified areas. This is known as the trabeculae (or 
trabecular or cancellous bone). The difference between the cortical and 
trabecular bone is their structure. Over 85% of cortical bone is mineralised 
whereas only 30% of the trabeculae is mineralised, the remainder of the 
volume being occupied by bone marrow, blood vessels and connective tissue. 
Cortical bone represents approximately 80% of total bone mass of the body, 
whereas trabecular bone represents only 20%. Trabecular bone is 
metabolically 8 times more active than cortical bone. As a consequence, any 
changes in bone due to age, diet or disease, are far more pronounced in 
trabecular bone. Two surfaces of the bone are in contact with soft tissue: The 
periosteal surface (external surface) and the endosteal surface (internal 
surface). They are lined with layers of cells, being the periosteum and 
endosteum, respectively [7].
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FIG. 2 MACROSCOPIC ORGANISATION OF THE BONE
(Taken from www.pathologyQutlines.com)
2.1.2 M IC R O S C O P IC  O R G A N IS A T IO N
Bone is basically made of cells and extra cellular matrix, which is composed 
of water, collagen, other non-collagenous proteins and minerals. The 
composition of bone depends on the site and other components such as diet, 
age and disease.
The mineral content accounts for 65% and is mainly composed of a calcium 
phosphate mineral, analogous to crystalline calcium hydroxyapatite [Cam 
(P0 4 ) 6  (OH)]] [6]. However, it is not 100% pure and can contain magnesium, 
potassium, strontium, sodium, carbonate and fluoride.
The organic matrix accounts for 35% with 90% of it being type I collagen. 
The remainder is non-collagenous proteins, lipids and other macromolecules.
Collagen molecules are arranged in such a way that cavities and gaps are 
formed, which enables mineral deposition and crystal formation. This gives
the typical lamellar structure to the bone. These lamellae are parallel when the 
bone is deposited along a flat surface (periosteum, for example), or concentric 
if the bone is on a surface that surrounds a blood vessel (Haversian system or 
osteon), such as in cortical bone (Fig 2). Also, other substances whose role 
cannot be described here, such as osteonectin, osteopontin, osteocalcin and 
bone sialoproteins, are also present in the bone matrix [7].
1. BONE CELLS
The three most common bone cells are osteoclasts, osteoblasts, osteocytes and 
their precursors.
7.7 06'7TOC7,y45'T&
The osteoclasts are responsible for bone resorption. They are large cells (20- 
100 pm) and are often found in contact with a calcified bone surface. They 
can be distinguished by the presence of a brush (ruffled) border that results 
from extensive in-foldings of the cell membrane adjacent to the resorptive 
surface. Enzymes, (cathepsin K for example), metalloproteinases and ions 
secreted through the brush border, degrade the inorganic and organic bone 
matrix.
Osteoclasts have haematogenous origins and are derived from cells in the 
bone marrow, which can also develop into monocytes and macrophages (Fig.
2.). The pathway which appears to differentiate these precursors into 
osteoclasts is the RANK-RANKL-OPG pathway (Fig. 3). The differentiation 
of osteoclasts proceeds when RANK binds to the receptor activator of nuclear 
factor kappa B ligand (RANKL), which is expressed on osteoblasts and 
marrow cells. Osteoprotegerin (OPG) is vital in this pathway as it is a soluble 
receptor for RANKL, which inhibits osteoclastogenesis and bone resorption. 
The amount of bone resorption is ruled by the precursor pool, as well as the
stimuli, for proliferation and differentiation of these cells into mature 
osteoclasts. A large quantity of hormones, espeeially parathyroid hormones, 
but also growth factors and cytokines play an important role in regulating 
bone resorption [3, 6-8]. The destruction of bone matrix by the osteoclasts 
sets free a measurable amount of collagen-telopeptides, which can be 
measured in blood and urine as a parameter of bone resorption.
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FIG. 3 RANK-RANKL-OPG PATHWAY  
(Taken from
http://www.aapspharmaceutica.com/inside/focus groups/ModelSim/imagespd
fs/04Peterson.pdf)
The osteoblasts are responsible for bone formation. They are derived from 
local mesenchymal stem cells and form clusters, lining the bone surface, 
where they secrete an organic matrix (Fig. 2.1.2.b). Osteoblasts produce 
alkaline phosphatase; hence serum alkaline phosphatase activity correlates 
with osteoblastic activity. Osteocalcin is also released into the circulation and 
consequently provides another marker of their activity. When procollagen is
transformed into collagen, large N- and C- terminal peptides are released. 
These can be measured in the circulation and reflect the overall rate of 
collagen synthesis. When the osteoblast stops secreting matrix, it is either 
embedded within the matrix and called an osteocyte, or it becomes a lining 
cell.
The osteoblast proliferation, differentiation and activity are influenced by 
numerous hormones such as androgens, estrogens, growth hormone, 1,25- 
dihydroxy vitamin D3, parathyroid hormone (PTH), leptin and cytokines 
(BMP’s for example) [4, 7].
/ . / / /
As already mentioned, some osteoblasts embedded in the matrix become 
osteocytes (Fig. 4). They are the most numerous cells in bone and are linked 
together by a net of plasmatic prolongations, providing a cellular connection 
with the bone surface. Their precise function remains unclear. One of their 
functions could be to play a role in the transduction of mechanical stimuli into 
changes of bone formation and resorption [7]. They secrete Sclerostin which 
inhibits bone formation by osteoblasts.
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FIG. 4 BONE CELL LINEAGE
(Taken from http://courses.washington.edu/bonephys/physiologY.htmn
2,1.3 M O D E L L IN G  A N D  R E M O D E L L IN G
Bone modelling mainly occurs in the growing skeleton, or during fracture 
repair. It is the process by which bone is formed, without prior bone 
resorption. Modelling can be influenced by mechanical stress. For example, 
bone mass increases in the most frequently used, long bones of athletes [9]. 
On the other hand, bone remodelling is the process in which resorption is 
followed by formation. This process is vital to the skeleton’s renewal and 
growth. It is the continuous destruction and formation of bone and has several 
functions.
Metabolically, it assists the maintenance of serum calcium homeostasis as 
99% of the body calcium is stored in the skeleton. Structurally, it preserves 
the skeleton’s integrity by repairing damage. Every year, 5-10% of the 
skeleton is renewed by remodelling. This activity is 5-10 times lower in 
cortical bone than in trabecular bone [10].
As shown in Fig. 5, the sequence of events is the activation of osteoclast 
resorption, the reversal phase, the formation and finally, the resting phase. 
The process is the same in trabecular and cortical bone, although it occurs on 
surfaces in trabecular bone and via tunnelling osteoclasts in cortical bone [11]. 
Each phase can vary, but generally lasts 5-10 days for the resorption phase; 
30-35 days for the reversal phase; and 50-100 days for the formation phase. 
In human adults, the entire sequence takes approximately 3-6 months. During 
this time, a pit of about 70-100 pm deep has been created and refilled with 
new bone matrix [11]. In normal circumstances, this process results in equal 
amounts of bone resorbed and formed. However, resorption can exceed 
formation in certain pathological conditions and during senescence, resulting 
in a net deficit in bone mass. Remodelling is more likely to occur at the site of 
micro-cracks (accumulated micro damage) [3, 7].
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FIG. 5 THE BONE REMODELLING CYCLE
2.2 Osteoporosis
2.2.1 D E FIN IT IO N
In 1991, osteoporosis was defined as “a disease characterised by low bone 
mass and micro-architectural deterioration of bone tissue, leading to enhanced 
bone fragility and a consequent increase in fracture risk” [12]. In 1994, the 
WHO Working Group defined osteoporosis according to measurements of 
bone mineral density (BMD) using dual-energy X-ray absorptiometry 
(DEXA). Thus, osteoporosis is defined as a bone density at or below 2.5 
standard deviations (SD) - below normal peak values for young adults (T- 
scores) [13] .
• Normal - a BMD value less than 1 SD (standard deviation) below the 
young, adult mean. This classifies 84.1% of the young, adult population as 
normal and 15.9% as abnormal.
• Osteopenia - a BMD value between 1 and 2.5 SD below the young, 
adult mean. This classifies 15.2% of the young adult population as 
osteopenic.
• Osteoporosis - a BMD value greater than 2.5 SD below the young, 
adult mean. This classifies 0.6% of the young adult population as 
osteoporotic.
• Established Osteoporosis - a BMD value greater than 2.5 SD below 
the young, adult mean and the presence of one or more fragility fi*actures.
These criteria were initially established for the assessment of osteoporosis in 
Caucasian women. BMD reports may include a “Z score”, which is the 
number of standard deviations by which the subject of interest differs from the 
mean for their age. This is of greater, clinical utility in younger individuals. 
The same absolute value of BMD can be used for the diagnosis of 
osteoporosis in men, since the fracture risk is the same in men and women for 
any BMD value at a given age. The WHO definition of osteoporosis takes 
only the bone density measurement into consideration, without regard to 
components of bone quality [13].
A clinical definition of osteoporosis was developed in 2001 by the NIH 
Consensus Development Panel on Osteoporosis. It stated: “Osteoporosis is 
defined as a skeletal disorder characterised by compromised bone strength, 
predisposing a person to an increased risk of fracture” [14]. This definition 
takes into consideration that there are other factors that influence bone quality, 
such as the micro-architecture of bone (Fig 6). However, measurement of 
BMD remains the most useful, clinical tool available for diagnosing 
osteoporosis.
It is also important to take risk factors for osteoporosis into consideration, in 
addition to measured bone mineral density, when making decisions about 
commencing treatment.
ÜFIG. 6 NORM AL BONE IN THE LEFT SIDE OF THE PICTURE AND OSTEOPOROTIC
BONE ON THE RIGHT
(Taken from http://www.osteoswiss.ch/frA
2.2.2 EPIDEMIOLOGY
Osteoporosis affects an estimated 75 million people in Europe, USA and 
Japan [15]. In 2000, there were approximately 9 million new osteoporotic 
fractures, of which 1.6 million were at the hip, 1.7 million were at the forearm 
and 1.4 million were clinical vertebral fractures. Europe and the USA 
accounted for 51% of all these fractures [16].
Recent epidemiological data from The Third National Health and Nutrition 
Examination Survey (NHANESIII) indicate that 13 to 18% of white American 
women aged 50 and over have osteoporosis of the hip. 37% to 50% have 
osteopenia. Prevalence increases from 4% in women 50 to 59 years old, to 
52% in women 80 and over [17]. The lifetime risk in the UK for a hip, spine, 
or forearm fracture at the age of 50 years has been estimated to be 53% in 
women and 20.7% in men. Moreover, it could be as high as 1 in 3 men in 
Australia over the age of 60 years [18]. The projected rise in osteoporotic 
fracture worldwide clearly demonstrates that the future impact of osteoporosis 
will be enormous. It has been estimated that there were 1.66 million 
worldwide hip fractures in 1990 and this figure is predicted to rise to 6.26 
million per year by 2050. The worldwide incidence of hip fracture is
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projected to increase by 310% in men and 240% in women by 2050 [19]. The 
highest increase will be observed in Asia and Latin America.
Moreover, hip fractures cause up to a 25% increase in mortality within one 
year of the fracture. 25% of women require long-term care and 50% have a 
long-term loss of mobility. In Europe, the disability due to osteoporosis is 
greater than that caused by cancers [16]. Osteoporosis fractures also create 
psychological problems due to pain, loss of mobility and independence, 
different body image and can alter mood and cause depression. The cost of 
these hip fractures was estimated at $34,800 million in 1990 and could reach 
$131,500 in 2050 [20]. Therefore, there is an urgent and critical need for 
public health strategies to reduce the predicted increase in osteoporosis in the 
population.
Fracture data for Switzerland
In Switzerland, between 2000 and 2020, osteoporotic hip, vertebral and 
forearm fracture are predicted to increase by 33, 27 and 19%, respectively, if 
present prevention and treatment patterns remain the same [21]. In terms of 
duration of stay, the annual cost of hospitalisations for osteoporotic fractures 
is higher than those for myocardial infarction, stroke and breast cancer, and 
only slightly lower than for chronic obstructive pulmonary disease. For 
women, the costs associated with osteoporosis were higher than for all these 
diseases [22]. In 2000, 62,535 hospitalisations for fractures were registered. 
51% of all fractures in women and 24% in men were considered as 
osteoporotic. The direct medical cost of hospitalisations for patients with 
osteoporosis and/or related fractures was £300,000,000. Hip fractures 
accounted for nearly half of these costs [23].
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Fracture data
Fractures occurring in women are 58, 75, 70 and 80% forearm, humerus, hip 
and spine, respectively. Overall, 61% of osteoporotic fractures occur in 
women, with a female-to-male ratio of 1.6 [16]. A 10% loss of bone mass in 
the vertebrae can double the risk of vertebral fractures, and similarly, a 10% 
loss of bone mass in the hip can result in a risk of hip fracture 2.5 times 
greater [24]. In white women, the lifetime risk of hip fracture is 1 in 6, 
compared with a 1 in 9 risk of diagnosis of breast cancer [25]. In women over 
45 years of age, osteoporosis accounts for more hospitalised days than many 
other diseases, including diabetes, myocardial infarction and breast cancer 
[26]. Evidence suggests that many women who sustain a fragility fracture are 
not appropriately diagnosed and treated for probable osteoporosis [27-28]. 
The great majority of individuals at high risk (possibly 80%), who have 
already had at least one osteoporotic fracture, are neither identified nor treated 
[29]. A survey undertaken by the International Osteoporosis Foundation, 
conducted in 11 countries, showed denial of personal risk by postmenopausal 
women, lack of dialogue about osteoporosis with their doctor, and restricted 
access to diagnosis and treatment before the first fracture, resulting in under­
diagnosis and under-treatment of the disease [30].
Osteoporosis in men
Although women are more at risk of suffering from osteoporosis, men are also 
susceptible to suffer from it. This is comparable to the lifetime risk of 
developing prostate cancer. About 20-25% of hip fractures occur in men. The 
overall mortality is about 20% in the first 12 months after hip fracture and is 
higher in men than women [31-32]. It is estimated that the lifetime risk of 
experiencing an osteoporotic fracture in men over the age of 50 is 30% [33],
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similar to the lifetime risk of developing prostate cancer [34]. Vertebral 
fractures may cause equal morbidity in men and women, and hip fractures 
causing significant morbidity and loss of normal functioning [35]. Although 
the overall prevalence of fragility fractures is higher in women, men generally 
have higher rates of fracture related mortality [32, 36]. As in women, the 
mortality rate in men after hip fracture increases with age and is highest in the 
year after a fracture [37-38]. Over the first 6 months, there is approximately 
double the mortality rate in men, compared to women of a similar age. 
Forearm fracture is an early and sensitive marker of male skeletal fragility. In 
aging men, wrist fractures carry a higher, absolute risk for hip fracture than 
spinal fractures, when compared to women [39].
2.2.3 PA TH O G E N E SIS
Osteoporosis is a skeletal disorder characterised by two elements that 
distinguish it from osteopenia and osteomalacia: Low bone mass and micro- 
architectural disruption.
• Low bone mass is a characteristic of osteoporosis by definition.
• The normal architecture is disrupted. There is less skeletal structure in 
osteoporotic bone and it is thinner than normal; in addition, there are 
horizontal skeletal structures which do not join up and consequently, 
provide no structural support.
This micro-architectural disruption has a negative impact on the structural 
integrity of the bone, and leads to major clinical features of osteoporosis: 
Skeletal fragility and an increase in fracture risk [1].
The mechanisms of the micro-architectural disruption are not clear. Increased 
remodelling causes structural weakening, and this may account for the
independent association of high bone turnover with fracture risk [4]. Other 
possible factors include:
• Microffactures and fatigue damage.
• The development of perforations and discontinuities in trabecular bone, 
as well as a relatively excessive loss of horizontal trabeculae.
• "Macro-architecture" may play a role; as an example, increased length 
of the femoral neck increases the risk of hip fracture.
• Muscle strength, posture and the frequency and type of falls affect 
fracture frequency and site.
A decrease in bone mass can be caused by low peak bone mass, excessive 
bone resorption, or decreased bone formation during remodelling. All three 
processes are likely to contribute, in varying degrees, to osteoporosis in 
individual patients. Their relative contribution to fracture risk is not known, 
but it seems likely that increased bone resorption has the greatest impact [5,6]. 
Bone loss related to age and menopause are clearly important pathogenetic 
factors, but their expression must vary because there are wide variations in the 
amount of bone and "porosity" of bone in older people of the same age [7].
2.2.4 D E T E R M IN A N T S  OF P E A K  B O N E M A S S
Twin studies have shown that genetic determinants account for 40 to 80 
percent of the differences in peak bone mass. Skeletal structure and bone 
turnover are probably also genetically determined, but environmental factors 
affect bone growth during childhood and adolescence. Increasing calcium 
intake and physical activity has a small, but positive effect, on peak bone
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mass. Moreover, the late incidence of fragility fractures partially depends on 
the peak bone mass that has been created due to these lifestyle factors [8].
For example, calcium-enriched foods or calcium supplements (approximately 
1600 mg/day) promoted increased bone mass in children [9,10]. The effect 
lasted three to five years after the end of the supplementation in only one of 
the studies. [11, 12].
Genetics
There are crucial interactions between genetic and environmental factors. For 
example, the differences in bone mass, attributed to different alleles of the 
vitamin D receptor, may be dependent upon differences in calcium intake [13].
Many genes have been examined for their possible role in the pathogenesis of 
osteoporosis [14,15].
• Different alleles of the gene for the vitamin D receptor are associated 
with small differences in bone mass [13]. However, the differences are 
not consistent among studies, and there is little evidence for a general 
association between vitamin D receptor alleles and osteoporosis [14- 
16].
• Increased frequency of osteoporosis has been reported in some patients 
with a particular single nucleotide polymorphism (SNP), of an Sp-1 
cleavage site, in the first intron of the collagen gene [14,15]
• Other genes, including those for the estrogen receptor, transforming 
growth factor-beta, and apolipoprotein E, have also been implicated in 
osteoporosis [40].
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• A report based upon an extensive linkage analysis, suggested that 
polymorphisms in the bone morphogenetic protein-2 (BMP-2) gene, 
were associated with an increased risk of fracture and low BMD in 
both pre- and postmenopausal women of Northern European descent 
[17].
• An activating mutation of the gene for a low-density-lipoprotein (LDL) 
receptor-related protein 5 (LRP-5) was associated with high bone mass, 
as an autosomal dominant, in several families [18,19]. Transgenic 
mice carrying the activating mutant have increased bone mass and 
strength. Deletion of the LRP-5 gene causes an unusual autosomal 
recessive disorder, osteoporosis-pseudoglioma syndrome, in which 
bone mass is markedly reduced [20].
Genetic studies have suggested that polymorphisms in the gene for LRP-5, as 
well as the cognate-like receptor LRP-6, may play a role in the regulation of 
bone mass, as well as fracture risk [21-24].
Further studies are required on the relationship between genetics and 
osteoporosis in order to establish their affect on treatment. In the future, some 
of the variability in the clinical course of osteoporosis could be explained. 
However, at the current time, there is not enough evidence to support the 
genotyping of candidate genes in practice.
2.2.5 M E C H A N IS M S  OF BO NE LOSS  I N  O S T E O P O R O S IS  
Increased bone resorption or decreased bone formation lead to bone loss. 
Evidence shows that osteoporosis is linked with increased bone resorption, 
which is observed in the morphologic pattern of trabecular bone loss and 
increased cortical porosity. However, bone biopsies in osteoporotic patients
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show a limited increase in actively resorbing surfaces, together with a decrease 
in bone formation [27,28].
The relative contributions of increased resorption and decreased formation 
probably represent a continuum, and this relation may change during the 
course of the disease. Biopsies of patients with advanced osteoporosis usually 
show decreased osteoblastic activity [27], but this could be the final stage of a 
process that started with excessive resorption.
2.2.6 R O L E  OF H O R M O N E S  I N  O S T E O P O R O S IS
Changes related to age and menopause in the production of many hormones 
have been identified. However, there are no differences in the hormonal 
serum concentrations for patients with osteoporosis and suitably matched 
control subjects. Nevertheless, the changes in calcium-regulating hormones, 
sex hormones, and growth-regulating hormones that appear with age, probably 
contribute to osteoporosis, or at least result in increased susceptibility to other 
factors that might cause osteoporosis.
Calcium-regulating hormones
Hyperparathyroidism and vitamin D deficiency cause osteoporosis. Milder 
degrees of parathyroid hormone (PTH) excess or vitamin D deficiency 
contribute to the pathological changes of osteoporosis.
Secondary hyperparathyroidism can be induced by decreased calcium and 
vitamin D intake and low sun exposure, which plays a role in age-related bone 
loss [29]. A study showed that women undergoing hip replacement because of 
hip fracture had lower serum 25-hydroxyvitamin D concentrations, than 
women with or without osteoporosis, who had been admitted for elective hip 
replacement [30]. Hyperparathyroid bone loss is associated with higher loss of
cortical than trabecular bone and more preservation of trabecular connections, 
as compared with osteoporosis.
While bone turnover is decreased in patients given exogenous calcitonin [31], 
endogenous calcitonin is not an important determinant of osteoporosis. In 
addition, where the calcitonin gene had been deleted in mice, there was an 
increase in bone mass [32]. This intriguing result suggests that either 
calcitonin itself or calcitonin gene-related peptide, which is a product of the 
same gene, has an effect on osteoblasts.
Estrogen
The crucial role of estrogen deficiency, in the pathogenesis of osteoporosis in 
postmenopausal women, is well documented. Estrogen inhibits bone 
resorption and, after the menopause, estrogen deficiency results in increased 
bone resorption and fast bone loss. The loss decreases with time after 
menopause, but the bone loss that continues years after menopause is 
associated with relatively high levels of markers of bone resorption in many 
women. Women aged 70 years or more, who continue to produce small 
amounts of estradiol, have a significantly lower risk of hip and spine fractures 
than those who do not [33]. Serum estrogen concentrations are also correlated 
with bone mass in older men [36, 37].
Estrogen administration decreases both bone resorption and formation in 
females, even several decades after the menopause [40]. The decrease in bone 
formation has been considered secondary to a reduction in the number of 
resorption cavities, where coupled formation normally occurs. Nevertheless, 
the resorption spaces are filled in, and bone mass usually increases or stops 
decreasing with estrogen therapy [41].
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The mechanisms by which estrogen regulates bone remodelling are not fully 
known [42]. It does not inhibit osteoclastic bone resorption in many in vitro 
systems, but is thought to affect osteoclastogenesis and osteoclast function 
[43]. Estrogen also decreases the depth of the erosion cavity caused by the 
osteoclast [44]. While there is substantial evidence for direct actions of 
estrogen on bone cells, indirect mechanisms involving other cells in the 
marrow, particularly T-cells, have also been implicated [45,46].
There is substantial evidence that estrogen deficiency induces increased bone 
resorption. However, there may be an additional defect in the bone formation 
response to increased resorption in estrogen deficiency [47].
Androgens
Androgen deficiency results in bone loss with increased bone turnover, similar 
to that which occurs in estrogen deficiency. For females, the relative 
importance of androgens (mainly testosterone) and estrogens (mainly 
estradiol), derived from androgen metabolism, is not known, but androgens 
may directly stimulate bone formation [56].
Androgen deficiency occurs with aging, and studies in postmenopausal 
women suggest that low serum androgen concentrations contribute to the bone 
loss associated with estrogen deficiency [57].
Glucocorticoids
The use of Glucocorticoid is a cause of osteoporosis. It induces inhibition of 
bone formation, due to decreases in the replication, migration, differentiation 
and life-span of osteoblasts. This is associated with changes in the production 
of local growth factors, including insulin-like growth factors (IGF) and their 
binding proteins, together with prostaglandins. Increased bone resorption can
also occur. This may be due to impaired calcium decreased estrogen and 
androgen production. One other factor that contributes is the underlying 
inflammatory disorder for which the glucocorticoids are given.
Growth hormone/insulin-like growth factor
The growth hormone-IGF system is a major determinant of skeletal growth. 
Growth hormone or IGF-I deficiency, as well as receptor defects, result in 
dwarfism and diminished bone mass. However, their role in most patients with 
osteoporosis is probably small [64,65]. However, it has been shown that 
protein supplementation in osteoporotic elderly increases BMD and IGF. The 
same has been reported with milk in children. There is an age-related decrease 
in growth hormone secretion, serum IGF-I and IGF-binding-protein (IGFBP)- 
3 concentrations in both men and women [66]. IGF-1 is also a local hormone 
and decreased concentrations in bone have been reported in hip fracture 
patients [68].
Prostaglandins
Prostaglandins are regulators of bone cell function [89]. They increase both 
bone resorption and formation. A role for prostaglandins in osteoporosis 
seems likely, based on the fact that so many of the local and systemic factors 
that regulate bone metabolism also affect prostaglandin synthesis in bone. 
Endogenous prostaglandins also appear to play a role in the skeletal response 
to mechanical forces [89,90].
Excessive prostaglandin production might lead to increased bone resorption, 
while deficient prostaglandin production might impair the bone formation 
response, both to mechanical loading and remodelling. Ovariectomized rats 
showed an increased production of Prostaglandin production in bones, which
decreased after estrogen treatment [91]. Prostaglandins have also been 
implicated in the increase of bone resorption, but not the reduced bone 
formation associated with immobilization [92].
PTH-related protein
PTH-related protein (PTHrP) is produced by bone and cartilage cells, as well 
as by some malignant tumours. It has an important regulatory function in the 
development of bone and cartilage, stimulates tubular re-absorption of 
calcium, causes pareneoplastic hypercalcemia when increased in some cancer 
diseases, and may also have a local, regulatory function in adult bone [101].
PTHrP, which is secreted by the lactating mammary gland, may play a role in 
the increased rate of bone resorption and rapid bone loss that occurs in 
lactating women [102].
2.2.7 D IA G N O S IS  OF O S T E O P O R O S IS  
Dual Energy X-ray Absorptiometry (DXA)
Bone density is assessed for the diagnosis of osteoporosis. There are several 
techniques, but dual-energy X-ray absorptiometry (DXA) is certainly the most 
commonly used method for diagnosing osteoporosis, as it measures bone 
mineral density (BMD) at the most important sites of osteoporotic fractures. 
DXA assesses the density of a surface expressed in g/cm^. The DXA 
diagnosis expressed in T-score, represents the interval in numbers of standard 
deviations, between the measured subject and the mean BMD of the reference 
population of the same sex and aged between 20 to 29 years.
DXA irradiates very little (~7pSv), the equivalent of the natural irradiation 
throughout the day, and 10 times less irradiation than a thorax X-ray.
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Furthermore, as well as the BMD measure, the most recent lateral DXA’s 
evaluate the vertebral morphology of the L4 to T4 vertebras. As a semi- 
quantitative visual method, the aim of this evaluation is to diagnose vertebral 
fractures that are often unknown, because they are very frequently 
asymptomatic [41].
The DXA should be performed based on a subject’s risk profile. Testing is 
recommended when the results will influence a treatment or management 
decision. Also, availability of equipment and insurance reimbursement have to 
be taken into account.
The North American Menopause Society [42] (NAMS) recommends that BMD 
be measured in the following cases:
- Postmenopausal women with medical causes of bone loss, regardless of 
age
- Postmenopausal women at least 65 years of age, regardless of additional 
risk factors [42].
Biochemical markers alone cannot diagnose osteoporosis.
Quantitative Ultrasound (QUS)
The Ultrasounds are sound waves beyond the audible threshold, defined as 20 
kilo hertz (kHz). The mechanical and physical properties of bone progressively 
alter the shape, intensity and speed of the propagating wave. Bone tissue may 
therefore be characterised in terms of ultrasound velocity and attenuation. The 
calculation of these parameters vary, depending on which manufacturer and 
model is being used [43].
For clarification and standardisation purposes amongst the different heel QUS 
devices, the 2007 ISCD Official Positions’ Expert Panel rated the following as 
appropriate terminology [43];
- Broadband Ultrasound Attenuation (BUA), in dB/MHz, is the 
recommended attenuation parameter.
Speed of sound (SOS), in metres per second (m/s), is the recommended 
velocity parameter.
- A composite parameter combining BUA and SOS, such as Stiffiiess 
Index (SI), may be clinically useful.
Potential advantages of QUS, compared with measurement of BMD, include 
lower expense, portability, and lack of radiation exposure. Measurements are 
most commonly made at the calcaneus, which is the only validated site.
QUS is particularly suitable in the research setting. Indeed, it is relatively low- 
cost and is a readily accessible alternative to dual-energy X-ray absorptiometry 
(DEXA) and it is safe [44]. DEXA allows accurate measurement of bone 
density, but does not provide information about the structural and qualitative 
features of bone. It is effective assessing fracture risk, the evidence being 
strongest for Caucasian females over 55 years old. Many studies have 
demonstrated that QUS measurements can discriminate normal subjects from 
osteoporotic patients [45].
QUS is a good predictor of osteoporotic fracture risk in postmenopausal women 
and men over the age of 65. In addition to predicting fracture risk, other studies 
have shown that QUS is at least as good as clinical risk factors for predicting 
osteoporosis risk in women [43]. However, studies do not show a reduction in 
fi-acture risk for patients selected for therapy on the basis of QUS measurements.
Therefore, QUS cannot be used to monitor the response to therapy, as changes 
are too slow to be clinically useful. If DXA cannot be done, pharmacological 
treatment can be initiated if the fracture probability is sufficiently high [43].
Peripheral DXA (pDXA)
pDXA devices are portable instruments that use the same technology as DXA, 
to measure BMD at peripheral sites, such as the forearm, calcaneus, or finger 
[46]. Evaluating the prediction of fracture risk with these devices is 
confounded by; technical differences, varied definitions as to which bone 
regions are of interest to be measured and lack of standardised reference 
databases for calculating T-scores. In addition, the pivotal therapeutic trials 
are not based on these measurements and for this reason, pDXA results cannot 
be used for defining the indication for treatment. Nevertheless, resulting low 
T-score values at peripheral sites, measured by pDXA devices, are associated 
with increased fracture risk. Despite generally good precision with pDXA, its 
clinical use is greatly inhibited by the fact that changes in BMD at peripheral 
skeletal sites are very slow in response to therapy. [46].
Quantitative computed tomography
Quantitative computed tomography (QCT) measures volumetric BMD 
(vBMD) in mg/cm^, most often at the spine. Unlike DXA, QCT can isolate 
trabecular bone from its envelope of cortical bone. Some studies have 
suggested that QCT of the spine may be a slightly better predictor of spine 
fracture risk than anterior-posterior spine DXA, perhaps because of the 
important contribution of trabecular bone to vertebral body strength [47]. 
However, another study suggested that QCT of the spine is not superior to 
DXA of the hip in predicting non-spine fracture [47].
QCT cannot be used for diagnostic classification, since the WHO criteria for 
BMD classification do not apply to this technology. It may be clinically 
useful to monitor changes in BMD over time for some patients with structural 
abnormalities of the spine that preclude the use of DXA. It has a potential role 
in monitoring the therapeutic effects of anabolic agents, or other types of drugs 
with novel mechanisms of action. At the present time, QCT is primarily a 
research tool that has been veiy helpful in improving our understanding of the 
pathogenesis of osteoporosis and the skeletal effects of drugs used to treat 
osteoporosis. It is more expensive, less reproducible, and requires a much 
higher radiation dose than DXA [47].
Emerging technologies
Although DXA is the most commonly used technique to assess BMD, it has 
some limitations. DXA measures areal BMD, rather than volumetric BMD. 
In addition, it cannot distinguish between cortical and trabecular bone, and it 
cannot assess bone micro-architecture. Thus, new technologies, such as high 
resolution microCT and microMRI have been developed, which allow non- 
invasive, three-dimensional evaluation of bone micro-architecture. Both 
techniques measure peripheral sites (distal radius, tibia). Preliminary studies 
suggest that alterations in micro-architecture, as detected by these techniques, 
are associated with fracture [48-49]. These techniques are used primarily in 
research settings.
Older technologies for measuring BMD
• Single-photon absorptiometry (SPA) — In SPA, a single-energy 
photon beam, generated from a radioisotope source, is passed through a 
peripheral bone, usually the radius or calcaneus. Bone density is
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estimated from the degree of attenuation of this x-ray beam. As the 
photon beam is single-energy, the machine cannot tell if the beam was 
attenuated by soft tissue or bone. As a result, SPA can be used only at 
peripheral sites, such as the radius and calcaneus. Low BMD at the 
radius and calcaneus, as measured by SPA, is associated with an 
increased risk of fractures [50], including hip fractures [51]. Currently, 
it is rarely used in clinical practice.
• Dual-photon absorptiometry (DPA) — DP A uses photon beams of two 
different energy levels from a radioisotope. As the two photon beams 
are attenuated differently by soft tissue and bone, bone density can be 
accurately estimated despite varying amounts of soft tissue. This 
feature allows DPA to measure bone density at clinically important, 
deep axial sites, such as the spine and hip. DXA has largely replaced 
DPA, which is now rarely used in clinical practice [52].
2.2.8 B IO C H EM IC AL M A R K E R S  OF B O N E  T U R N O V E R
Bone tissue is in continuous turnover during adult life. Old bone is removed 
and replaced by new bone, as a result of the coupled processes of bone 
resorption and bone formation. Bone mineral density measurement is most 
important in the clinical evaluation of patients at risk of osteoporosis. However, 
BMD is a static parameter, which does not give an insight into the rate of bone 
turnover. The possibility to complement the static BMD measurement, with the 
assessment of the dynamic process of bone turnover, could enhance the ability 
of BMD to predict the risk of subsequent fracture. The usage of biochemical 
markers as measurements offers a method which is non-invasive, relatively 
inexpensive, able to assess changes in bone turnover over short intervals of 
time, and can be applied repetitively.
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Each marker represents a product released into the circulation during the process 
of bone formation or resorption. Bone biochemical markers assess the balance 
between resorption and formation. However, these markers are not adequate to 
diagnose osteoporosis, or to predict bone mass. They may be useful in 
providing additional information on fracture risk beyond that provided by BMD. 
Bone turnover may be an independent predictor of fracture risk [53-55]. Bone 
markers can also be used to predict the rate of bone loss [56]. Additionally, they 
may be used for the selection of patients for therapy. Several studies indicate 
that patients with the highest levels of bone turnover seem to have the best 
response to anti-resorptive medication [57-58].
The clinical use of bone biochemical markers establishes them as the best 
method for monitoring the effectiveness of therapy. There is a significant 
reduction in markers of bone resorption within 4-6 weeks after the initiation of 
anti-resorptive therapy and within days after the administration of intra-venous 
bisphosphonates [59-60]. Bone turnover markers can be used to determine 
when therapy is ineffective. Anti-resorptive agents should produce a reduction 
of around 70% in the markers of resorption, depending on the agent and the 
markers. Failure to show the expected reduction in resorption markers could 
indicate non-compliance with the medication, or the need to change the 
medication. This use of biochemical markers offers an advantage over BMD 
assessment in order to clarify the effectiveness of therapy, because an interval of 
at least 12 months is required between BMD measurements, before any 
significant changes in BMD become apparent.
In the research setting, biochemical markers are particularly pertinent as they 
can predict the rate of bone loss and can also be used to assess the risk of
in
fractures. However, they are relatively expensive and might not be available in 
all research centers [61].
2.2.9 THE DIFFERENT BIO C H EM IC AL M A R K E R S  
Bone formation markers
- -the serum concentration of bone-specific, alkaline phosphatase reflects 
the cellular activity of osteoblasts [62-64].
- the serum concentrations of osteocalcin reflect the rate of synthesis of 
osteocalcin by osteoblasts.
- The serum concentration of the carboxy-terminal and amino terminal 
propeptides of type I collagen (PICP and PINP, respectively), reflects 
changes in synthesis of new collagen. The PNIP measurement appears 
to be more specific than PI CP for synthesis of bone collagen [65].
Bone specific alkaline phosphatase and PINP are the most clinically useful 
markers of bone formation.
Bone resorption markers
- The serum concentrations of skeletal acid phosphatase can be measured 
both by immunoassay and as tartrate-resistant acid phosphatase [62, 66].
- The urinary excretion of calcium provides a measure of the rate of 
dissolution of bone, but also depends upon the renal threshold for 
calcium, and on calcium intake.
- The urinary excretion of hydroxyproline reflects breakdown of collagen 
in bone, but is also influenced by the breakdown of collagen in other 
sites (cartilage, skin) and by dietary intake of collagen [67].
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- Urinary excretion of collagen crosslinks reflects bone resorption, but not 
dietary intake. Therefore, these substances are better indicators of bone 
resorption than urinary calcium or hydroyproline excretion [68].
Measurements of urinary NTX and serum CTX are the most clinically useful 
markers of bone resorption [69].
Practical aspects
When measuring markers of bone turnover, the diurnal variation in the serum 
concentration or urinary excretion of most markers must be taken into account. 
Indeed, there is a peak around 6am and a nadir around 6pm [70-71]. There is 
diurnal variation of creatinine excretion as well, complicating further the 
interpretation of urinary values, unless they are corrected for creatinine 
excretion [72]. The only markers that are not influenced by diurnal variation are 
PINP and serum bone specific alkaline phosphatase [62].
Assessment of fracture risk
Many studies have shown that low BMD is associated with an elevated risk of 
fracture. The lower the BMD, the higher the risk of fracture. However, because 
there are a greater number of people with osteopenia (T-score between -1 and - 
2.5) than osteoporosis (T-score <-2.5), the absolute number of fractures in 
subjects with BMD T-scores in the osteopenia range, is greater than those in the 
osteoporosis range. Most fractures occur in patients with T-scores higher than -  
2.5, and treatment strategies which rely only on BMD testing will miss many 
women at risk of fracture.
In 2008, a World Health Organisation task force introduced a Fracture Risk 
Assessment Tool (FRAX). This estimates the 10 year probability of hip
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fracture, or major osteoporotic fractures combined (hip, spine, shoulder or 
wrist), for an untreated patient using femoral T-score or Z-score and easily 
derived clinical risk factors for fracture [73]. FRAX is based upon data 
collected from large, prospective, observational studies of men and women of 
different ethnicities and from different world regions, in which clinical risk 
factors, BMD, and fractures were evaluated. The FRAX algorithm has been 
validated in 11 independent cohorts. New guidelines for the diagnosis and 
management of osteoporosis are attempting to incorporate these factors of risk 
fracture [73].
2.2.10 M E D IC A T IO N  T R E A T M E N T
The North American Menopause Society (NAMS) recommends drug therapy to 
the following population [42]:
- All postmenopausal women who have had an osteoporotic vertebral 
fracture
- All postmenopausal women who have BMD values consistent with 
osteoporosis
- All postmenopausal women who have T-scores from -2  to -2.5 and at 
least one of the following risk fractures: BMK21kg/m2, history of 
fragility fracture since menopause or history of hip fracture in a parent.
Several drug therapies exist for osteoporosis treatment: Bisphosphonates, 
SERM’s, PTH, estrogens and calcitonin. The adherence rate is poor. In studies 
of 6 months to 1-year duration, the adherence rates to the prescriptions ranged 
from less than 25% to 81%.
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I. Bisphosphonates
Several drugs belong to the bisphosphonate family: Alendronate, etidronate, 
risedronate, ibandronate and zoledronic acid. Bisphosphonates have been 
shown to inhibit the osteoclastic activity and reduce their life span, thereby 
reducing bone resorption. Bisphosphonates significantly increase spine and 
hip BMD and reduce the risk of vertebral fracture by 40% to 70% and non- 
vertebral fractures by approximately 25% in women with osteoporosis [74]. 
Some bisphosphonates also decreased hip fracture by 40-50%.
Bisphosphonates are licensed for the treatment of osteoporosis in post 
menopausal women. The 10 mg daily tablets of Alendronate are also used for 
men to reduce the risk of spinal and hip fractures [75]; the treatment of 
glucocorticoid induced osteoporosis; and the prevention of bone loss in male 
and female steroid users, considered at high risk of broken bones [76]. It may 
also be used for the prevention of osteoporosis in those post-menopausal 
women considered at risk of developing the disease, although current 
guidelines recommend that it is best targeted at people whose current risk of 
fracture is high. It should be avoided by individuals whose kidneys are not 
functioning normally, specifically those whose kidney impairment has been 
classed as moderate to severe. It can potentially cause irritation in the 
oesophagus so should not be given to people who already suffer from upper 
gastrointestinal tract problems and it is recommended to stay upright (sitting, 
standing or walking) for at least 30 minutes after taking the tablet [77]. These 
side effects are avoided by the use of intravenous bisphosphonates, which 
reveal themselves to be highly efficient.
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Secondary effects
Nausea, stomach pains, inflammation of the tongue and joint pain have been 
reported with the use of oral bisphosphonates. There is some information 
suggesting a link between bisphosphonates and osteonecrosis of the jaw. This 
rare condition seems to be associated mostly with very high doses of 
bisphosphonate drugs, given intravenously for cancer [78].
II. SERMs
SERMs or Selective Oestrogen Receptor Modulators mimic the action of the 
oestrogen hormone on certain tissues or organs. They decrease bone turnover 
and significantly increase BMD. After 3 years of therapy, SERMs reduced the 
risk of vertebral fracture by 55% in osteoporotic women. No effect has been 
observed on other non-vertebral fractures [79-80].
III. PTH
The parathyroid hormone directly stimulates osteoblasts and increases bone 
formation in trabecular bone, increasing BMD in postmenopausal, 
osteoporotic women. It differs from other available treatments which work by 
suppressing the action of the osteoclasts responsible for breaking down bone. 
PTH is the first treatment to renew the skeleton by stimulating the osteoblast 
[81] and is currently used as daily subcutaneous injection in postmenopausal 
women and men who have established osteoporosis. PTH treatment is more 
expensive than other treatments.
There is evidence that fractures are reduced by 50% after giving PTH 
treatment for at least another 18 months. The most commonly reported side 
effects in people using PTH treatment are nausea, limb pain, headache and 
dizziness.
The incidence of new vertebral fractures is reduced by 65% and 53% for non 
vertebral fractures [35, 82]. PTH offers benefits to patients across a broad range 
of age and disease severity [83].
IV. Oestrogen or Hormone Replacement Therapy (HRT)
Oestrogen affects bone and calcium metabolism as both osteoblasts and 
osteoclasts contain functional oestrogen receptors. Oestrogen acts through 
these receptors and restrains the increase of bone turnover, whilst maintaining 
coupling between bone formation and bone resorption. The loss of these 
direct effects of oestrogen on bone cells after the menopause, leads to a rapid 
phase of increased bone loss, which lasts for up to a decade. It has appeared 
that oestrogen also maintains calcium balance by its effects on extra-skeletal 
calcium metabolism. Oestrogen enhances calcium absorption, perhaps by 
increasing the sensitivity of the intestine to vitamin D action. It also appears 
to act directly on the kidney to increase tubular re-absorption of calcium.
HRT given at the menopause prevents short-term bone loss. Continuous HRT 
in postmenopausal women greatly reduces the extent of bone loss over life. 
HRT should be continued indefinitely, as studies show that for a period of 10 
years after it has been stopped, bone density and fracture risk are similar in 
women who have used HRT and those who have not. In clinical trials, 
oestrogen reduces bone turnover and increases bone density in 
postmenopausal women of all ages, partly due to the fact that it improves 
calcium homeostasis. The effect on bone mass is potentiated by calcium 
supplementation.
Observational studies have shown that oestrogen reduces the risk of hip 
fracture by about 30%. As with the data on bone loss, oestrogen therapy
should be continued indefinitely for preservation of its effectiveness as an anti­
fracture [84]; however, the fear of an increased risk of breast cancer prevents 
this.
Two large studies have studied the effects of estrogen.
1) Women’s Health Initiative randomised controlled trial [85]
The WHI was launched in 1991 and consisted of a set of clinical trials and an 
observational study, which together involved 161,808 generally, healthy 
postmenopausal women aged 65 and older.
The clinical trials were designed to test the effects of postmenopausal hormone 
therapy, diet modification, and calcium and vitamin D supplements on heart 
disease, fractures, and breast and colorectal cancer.
Compared with the placebo, oestrogen plus progestin resulted in:
Increased risk of heart attack 
Increased risk of stroke 
Increased risk of blood clots 
Increased risk of breast cancer 
Reduced risk of colorectal cancer 
Fewer fractures
No protection against mild cognitive impairment and increased risk of 
dementia
Compared with the placebo, oestrogen alone resulted in:
No difference in risk for heart attack 
Increased risk of stroke
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• Increased risk of blood clots
• Uncertain effect for breast cancer
• No difference in risk for colorectal cancer
• Reduced risk of fracture
However, it must be pointed out, that this trial has been criticized by many 
scientists and epidemiologists for its lack of validity. Furthermore, the 
duration of the study might be too short as breast cancer may develop in a 
longer time period [86].
2) The Million Women Study [87]
HRT and breast cancer
Follow-up of over 1 million women in the Million Women Study confirmed 
findings from other recent studies, that women currently using HRT are more 
likely to develop breast cancer, than those who are not using HRT. Past users 
are not at increased risk. The Million Women Study was able to show that this 
effect is substantially greater for combined (oestrogen-progestagen) HRT than 
for oestrogen-only HRT; and that the effects were similar for all specific types 
and doses of oestrogen and progestagen, for oral, transdermal and implanted 
HRT, and for continuous and sequential patterns of use. Use of HRT by 
women aged 50-64 in the UK in the decade from 1993-2003 resulted in an 
estimated 20,000 extra cases of breast cancer.
As previously discussed about the Women’s Health Initiative study, the 
Million Women Study has also been quite broadly criticized amongst the 
scientific world. The biases in the design make the results largely 
uninterpretable. It has been discussed whether the conclusion that HRT
increases the risk of breast cancer is really justified. Indeed, findings from this 
study are discordant with those reported in other studies [8 8 ].
V. Calcitonin
Calcitonin is available in an injectable form and a nasal spray. It is a hormone 
which is found naturally in humans and animals alike and it acts on the skeleton 
by regulating the amount of calcium in the blood. Calcitonin inhibits bone 
resorption. However, the reduction in bone turnover is much lower than with 
other anti-resorptive agents. In the PROOF trial, 200UI/day during 5 years in 
osteoporotic postmenopausal women, reduced the risk of new vertebral fracture 
by 33%, compared with placebo. It has also been shown to reduce bone pain 
straight after a vertebral compression fracture. Its efficacy has not been shown 
in early, postmenopausal women [89-90].
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2.2.11 FA C TO R S IN FLU EN C IN G  FRAC TU RE R IS K  O TH ER  
TH A N  N U T R IT IO N
Numerous factors other than nutrition influence the risk of fracture. Figure 7 
below, shows the most important ones:
Advanced age 
Low BMD
Previous fracture (other than skull, facial bone, ankle, finger, and toe) 
as an adult 
History o f hip fracture in a parent
Thinness [body weight <127 lb (57.7 kg) or low  BM l (<21 k g /n f)]  
Current smoking, any amount 
Low calcium or vitamin D intake 
More than two alcoholic drinks per day 
Oral or intramuscular glucocorticoid use for >3 mo 
Increased fall risk 
Impaired vision  
Dementia 
Poor healtli/frailty 
Low physical activity 
History o f  recent falls
B M D , bone mineral density; B M I, body m ass index.
FIG. 7 FACTORS INFLUENCING FRACTURE RISK
I. Thinness and obesity
A positive correlation has been shown between body weight and bone density. 
Thinness significantly increases fracture risk, especially in older women [91- 
92]. This is however, not only due to low body weight, but more so to low body 
mass. There is a correlation between lean body mass and BMD, and the 
difference between men and women concerning BMD disappears, when BMD is 
corrected by low body mass.
An
On the other hand, obesity might also detrimental for the skeleton. Osteoporosis 
and obesity are growing in prevalence. Both pathologies share several features 
including a genetic predisposition and a common progenitor cell. With aging, 
the composition of bone marrow shifts to favor the presence of adipocytes, 
osteoclast activity increases, and osteoblast function declines, resulting in 
osteoporosis. Secondary causes of osteoporosis, including diabetes mellitus, 
glucocorticoids and immobility, are associated with bone-marrow adiposity 
[93].
The mechanisms involved could be the following:
-inflammatory cytokines impair bone formation 
-fatty acids stimulate resorption 
-Leptin inhibits bone formation via sympathetic system 
-Hyperglycemia impairs bone formation 
-Insulinopenia impairs bone formation [93]
II. Smoking
Female smokers have lower bone density, higher rates of bone loss and reach 
menopause two years earlier than non-smokers. The effect of smoking seems to 
be related to alterations in the estrogen metabolism, the suggested cause being 
an increase in hepatic conversion of estradiol into inactive metabolites at the 
expense of active hormones estrone and estriol. Smoking reduces the benefit of 
HRT and another study showed no difference in the rate of bone loss between 
smokers on a supplement of estrogen and those who weren’t [94]. Nevertheless, 
smokers appear to have impaired calcium absorption. In men, smoking is also
A1
associated with lower bone density, increased rate of bone loss and higher 
fracture risk [95-96].
III. Alcohol
In the Framingham study, alcohol consumption (>200mL/wk) increased hip 
fracture and the risk of falling. Even two glasses of alcohol a day significantly 
increase fracture risk. However, moderate alcohol consumption < 30-60 mL/wk 
in women aged 65 and over is associated with higher BMD and a decreased risk 
of hip fracture [97].
IV. Physical activity
Several studies on the effect of bone loss during space flights due to long-term 
immobilisation and weightlessness prove the critical importance of gravity 
forces in preserving bone density [98]. Part of the loss of bone density that 
accompanies aging, is due to the decrease of physical activity levels in later life. 
High-impact activity in pre-menopausal women and young men results in a 
slight increase in bone mass. Physical inactivity also decreases muscle strength 
and increases the risk of fall. Even in previously sedentary subjects, initiating 
exercise increases bone density and slows bone loss [99-100].
V. Heredity
Heredity has the greatest influence on women’s peak bone mass, i.e., up to 80% 
of the variability in peak bone density. Also, the risk of hip fracture risk is 50- 
127% higher if  a hip fracture has occurred in a parent [101].
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VI. Menopause status
Just after the menopause, bone turnover and the rate of bone resorption increase, 
indicating the role of oestrogen on BMD in women. For several years around 
the menopause (2-3 years before to 3-4 years after), women lose bone at an 
annual rate of 2%. The earlier the menopause, the greater the risk of having low 
BMD [42].
VII. Previous fractures
The incidence of low trauma in the history of a given individual increases the 
risk of further fractures by at least two fold, since it proves the presence of 
brittle bones.
VIII. Other causes
There are various other risk factors for fracture, such as medications (oral 
glucocorticoids for example), gastrointestinal diseases, genetic disorders, and 
endocrine diseases amongst others.
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2.3 Nutritional factors influencing bone health
Bone has the same nutritional needs as other tissues, not only in terms of 
energy, but also in terms of macro- and micro- nutrients. Therefore, 
malnourishment affects skeletal growth and specific bone abnormalities 
characterise these nutritional deficiencies [1 0 2 ].
2,3.1 C ALC IU M  A N D  BO N E H E ALTH
The adult human body contains approximately 1000 g of calcium, with 99% 
localised in the skeleton and teeth. Under the hydroxyapatite form, calcium 
gives the skeleton its mechanical properties. In its ionised form, calcium 
influences the essential functions of muscular contraction, nervous conduction, 
blood coagulation, activation of certain enzymes, liberation of 
neurotransmitters, hormonal secretion, cellular mobility and division. Normal 
calcemia is lOOmg/L and is maintained by the intestinal calcium absorption, 
bone resorption and the renal tubular re-absorption. These different functions 
are regulated by endocrine mechanisms. Approximately only 25% of calcium 
intake is absorbed in the digestive tube. Several nutritional factors interact 
with calcium intestinal absorption and renal excretion :
Table 1 Nutritional factors influencing calcium intestinal
absorption [103]
Intestinal absorption
Factors increasing intestinal resorption Factors decreasing intestinal absorption
Low calcium intake High calcium intake
Fibre Phytates, oxalates
Lactose Fat
Hormones (Vitamin D and E2) Caffeine
Renal excretion
Factors increasing urinary excretion Factors decreasing urinary calcium
Proteins Potassium
Sodium Alkali diet
Chlorides
Acid diet
AA
Calcium intake is a major determinant in the acquisition of peak bone mass. 
Several studies have shown a significant correlation between calcium 
supplementation in children or adolescents and bone mineral density [104- 
105] and growth.
In pre-menopausal women, the impact of calcium on bone mineral density is 
not always proved. Several studies on women under 40 did not show a 
relation between vertebral or femoral bone density and calcium intakes. 
However, more recent studies have shown a positive effect [28, 106]. In 1995, 
Welten et a l undertook a meta analysis of around 20 published studies and 
concluded a positive effect of calcium intakes and bone mineral density in 
women aged between 25 to 40 years old [107].
After the menopause, several studies have shown that a calcic supplementation 
is not sufficient to stop bone loss [108-109]. Calcium supplementation 
associated to HRT treatment has shown a positive effect. An analysis of 31 
publications, concerning the simultaneous effect of HRT and calcium 
supplementation in postmenauposal women, demonstrated that the HRT effect 
was more than doubled when calcium intake increases from 589 mg to 1189 
mg [1 1 0 ].
In old age, the decrease in intestinal calcium absorption is associated with a 
decreased dietary intake and a deficient vitamin D status, as well as a 
compensatory hyperparathyroidism [1 1 1 ], which leads to an increase in bone 
resorption [112]. However, a vitamin D supplementation is very efficient to 
correct deficiency in old people and this also has a beneficial effect on bone. 
Therefore, a calcium and vitamin D supplementation in older people is an 
important factor to prevent osteoporosis and fractures [113].
2.3.2 P R O T E IN  A N D  BO N E H EALTH
Recommended protein intake is linked to the specific needs in amino acids 
and more particularly, to essential amino acids. Malnutrition in childhood or 
adolescence leads to decreased bone mass and delayed growth. This is not 
only due to a deficiency of energy intake, but also to a deficiency of protein 
intake and is proven to be the case in old age. Therefore, if malnutrition 
occurs, this may be detrimental to the acquisition of peak bone mass and to 
maintenance of the skeleton during aging [104, 114-115]. On the other hand, 
an excess in protein intake could also have a detrimental effect on bone by 
increasing urinary calcium excretion [116]. The risk of insufficient protein 
intake increases with aging. In addition, the capacity to generate anunonium 
ions and decrease the acid charge, by excreting hydrogen ions, is diminished. 
For these reasons, an acid diet results in a lower serum pH in older people 
[117]. However, a sufficient calcium intake could improve the intestinal 
absorption and compensate the calciuric effect of proteins [118].
The metabolism of sulphur (methionine and cysteine) amino acids from 
nutritional proteins generates an acid charge which, in turn, lead to a decrease 
in serum and urinary pH [119-120]. A positive correlation between urinary 
calcium excretion and metabolic acidosis has been shown [121]. To buffer the 
acidity, calcic salts from the skeleton are used. This phenomenon can induce 
bone loss, inhibit the osteoblastic function and stimulateubone resorption [1 2 2 - 
123].
Conversely, an insufficient protein intake is detrimental to the skeleton. 
Kerstetter et al showed that a secondary hyperparathyroidism and a decrease 
in calcium urinary excretion, is probably linked to a decrease in intestinal 
mineral absorption [124]. Furthermore, protein intake is correlated to plasma
levels of IGFl, a growth factor particularly implicated in the regulation of 
osteoblastic activity [125].
The Nurse’s Health Study demonstrated that the incidence of forearm 
fractures was higher in subjects with a high protein intake (>95g/day). At the 
other extreme, hip fractures are more frequent in the elderly with a low protein 
intake. For elderly patients with a recent hip fracture, a protein supplement is 
beneficial [126].
2.3.3 P H O SP H O R U S A N D  BO N E H E ALTH
The RNI for phosphorus are lower than those for calcium. In the western diet, 
phosphorus intake is always higher than the RNI. Consequently, there is 
concern over a daily consumption of phosphorus which is significantly above 
the RNI.
The skeleton is the organ with the highest phosphorus content. Phosphorus 
actually makes up more than 50% of the bone mineral mass. The 
hydroxyapatite in bone is composed of calcium phosphate salts. The human 
body contains approximately 700g of phosphorus, 85% of which is associated 
with the calcium in the skeleton and teeth.
In 2002, Neville et al showed a negative correlation between phosphorus 
intake and femoral mineral density in adolescents, which continues through to 
adulthood [127]. In calcium deficiency, phosphate load increases PTH and 
bone resorption, which can be corrected with calcium. In calcium sufficiency, 
a phosphate load has no effect on bone metabolism. An insufficient phosphate 
intake has been found in 1 0 % of women over 60, and in 15% of women over 
80 years [128]. Since calcium supplements decrease phosphate absorption, it 
has been speculated that the increase of hip fractures observed with calcium 
supplements is due to phosphate deficiency [128].
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2.3.4 SO D IU M  A N D  BO N E H E ALTH
Sodium is generally associated to Chloride in the form of NaCl. The 
organism’s homeostasis requires a daily intake of 1 to 2g of NaCl. Several 
studies have shown that a high sodium intake induces an increase in urinary 
calcium excretion, via a decrease in the renal tubular re-absorption. Nordin et 
al. suggested that, for every 100 mmol (2.3 g) of urinary excreted sodium, 
there is 1 mmol loss of urinary calcium in the healthy population [129].
The calciuria can be decreased when the sodium chloride is substituted by 
potassium chloride. This concept is confirmed by the strong correlation which 
exists between calcium and sodium excretion.
In animals, a high sodium diet induces a decrease of the bone mineral content, 
and even more so if the calcium intake is low [130]. Furthermore, Jones et al 
showed a positive correlation between sodium excretion and bone resorption 
markers [131].
The same observations were found in post-menopausal women, where the 
change in bone mineral density is dependent upon the excretion of urinary 
sodium. This phenomenon was not found in young girls [132-134]. However, 
another study of young girls has revealed that a diet rich in sodium induced a 
significant decrease of the bone mineral density.
It appears that an excess of salt could induce osteopenia in adults and the 
elderly, whereas an adequate, moderate intake could reduce calciuria and 
therefore the rate of bone loss linked to age. The excess of salt is considered a 
risk factor for osteoporosis, although long-term studies are required to assess 
the effects.
It must be remembered that our pre-agricultural, hunter-gatherer ancestors 
consumed wild animal-source foods and uncultivated plant-source foods, a
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diet which was sodium poor and potassium rich. The potassium to sodium 
chloride ratio inverted with dietary shift. Indeed, our modem diet reflects a 
fall in the consumption of plant food and an increased consumption of sodium 
chloride [135].
Humans are not capable of adapting to this modem, contemporary diet, as the 
shift has occurred too recently for the genetic determination to adjust [136- 
137]. It has been suggested that the dietary pattems responsible for low-grade 
metabolic acidosis, as well as low potassium intakes and high sodium chloride 
intakes, contribute to the pathogenesis of osteoporosis and other age-related 
disorders [138-139].
2.3.5 P O T A SSIU M  A N D  BO N E H E ALTH
Potassium is an essential mineral, as it regulates the water balance and the 
acid-base balance in the blood and tissues, along with sodium. Potassium has 
a “buffering” effect on the organism and is primarily found in fruit and 
vegetables.
The skeleton can be considered as an alkaline reservoir because of the calcium 
salts it contains, which can be used during a decrease in blood pH (acidosis). 
Furthermore, a low potassium intake increases calcium urinary excretion in 
adults [140], whereas a potassium bicarbonate supplementation (60 mmol/d) 
in post-menopausal women, induces a significant decrease of this parameter
[141]. Potassium bicarbonate seems more efficient than potassium chloride
[142]. Indeed, a potassium bicarbonate supplement (60 to 120mmol/d) in 
post-menopausal women, decreased the rate of bone resorption at the same 
time as it stimulated the formation [123].
A transversal study on young children ( 8  years old) showed a positive 
correlation between urinary potassium and bone mineral density (femoral neck
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and lumbar spine) [134]. Tucker et al demonstrated that a high potassium 
consumption, as well as fruit and vegetables, slowed down menopausal bone 
loss in post-menopausal women [143]. New et al showed that an increase in 
the ingestion of potassium and fibre improved bone mineral density in pre­
menopausal women aged 45 to 49 years [144]. These results were confirmed 
by the same authors in 2000. Indeed, potassium consumption could explain 
18% of the variance found in forearm bone mineral density [145].
However, a recent study showed no effect of potassium. Indeed, a 
randomised, placebo-controlled study suggested that a two year potassium 
citrate supplementation did not decrease bone turnover or increase BMD at the 
spine or hip in post-menopausal, healthy women. Moreover, in the group of 
women who received a supplement of 300g of fruit and vegetables, no impact 
on bone turnover or BMD was shown [146]. This discrepancy remains so far 
unexplained.
2.3.6 M A G N E SIU M  A N D  BO N E H E A LTH
The human body contains 25g of magnesium, 55% of which is in the skeleton. 
Magnesium associated to the hydroyapatite crystals is freed during bone 
resorption. In 1998, Rude showed that a severe deficiency of magnesium 
disrupts the skeletal homeostasis by a decrease in PTH secretion, resulting in a 
hypocalcaemia [147]. It has been shown that osteoporotic, post-menopausal 
women have lower plasmatic magnesium levels, than non-osteoporotic 
subjects [148]. The mechanisms remain unclear.
Magnesium seems to directly stimulate osteoblastic proliferation, which 
would suggest that a deficiency could induce a decrease in bone formation 
[149]. A decrease may also be responsible for a modification in the skeletal 
resistance [150]. Subjects with a magnesium deficiency have also been shown
to have lower levels of 1,25 (OHjz-vitamin D and PTH, both of which have a 
direct effect on bone formation.
Magnesium also has an effect on adolescents and young women. Wing et al 
[1999], showed a positive correlation between magnesium intake and 
calcaneum mineralisation. It may therefore also play an important role in 
skeletal growth and development. Several studies have also shown the same, 
positive correlation in pre-menopausal women [144-145, 151]. In post­
menopausal women or the elderly, a positive correlation is also found between 
magnesium intake and bone mineral density [143].
Therefore, magnesium is important to bone health, is implicated in skeletal 
growth and in maintaining bone health during adulthood and old age. A 
deficiency in magnesium could be added as a risk factor for osteoporosis. It is 
unclear whether this beneficial effect is due to magnesium alone, or to the fact 
that magnesium is found in fruit and vegetables.
2.3.7 V IT A M IN  K  A N D  BO N E H E ALTH
Vitamin K can be classified into vitamin K1 (phylloquinone) and vitamin K2 
(menaquinones) and is fat-soluble. In the human diet, vitamin K1 is found in 
green leafy vegetables and some margarines and oils [152], while vitamin K2 
is found in meat and animal livers, in milk products and in eggs. Severe 
vitamin K insufficiency leads to a defective coagulation system.
It is necessary for the carboxylation of two bone matrix proteins, a step 
necessary for their binding to hydroxapatite:
1) Osteocalcin, which is synthesized exclusively by osteoblasts
2) Matrix Gla protein, which is a product of chondrocytes in cartilage and 
of smooth muscle cells in the vasculature
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Low vitamin K intakes have been correlated to hip fracture in both the 
Framingham and Nurses Health Study cohorts [153]. The link was between 
vitamin K intakes and fracture, not BMD. However, in the Framingham 
offspring cohort among younger women (mean age 59 y), a positive 
correlation between vitamin K1 intake and BMD was found [154].
Vitamin K deficiency is, however easily treatable and could be inexpensively 
eliminated.
2.3.8 M IN E R A L  W A TE R S
The consumption of mineral and bottled waters has recently increased [155]. 
Over the last decade, for example, the consumption of mineral water has more 
than doubled in the USA and Switzerland. Mineral waters now have a 
prominent place in the diet of industrialised countries [156]. For this reason 
alone, their impact on health needs to be assessed [155]. There are different 
types of bottled water: Spring or artesian water, well water, purified water and 
sparkling, bottled water [1 2 1 ].
Natural mineral water distinguishes itself from other bottled waters by its 
specific, underground, geological origin, its stable composition of minerals, 
and its original purity [157]. To avoid any alteration, natural mineral water 
must be bottled at source and can only undergo a strictly limited number of 
expressly authorised treatments. According to the geological pattems of the 
catchment areas, very large variations exist in the composition of different 
mineral waters [121]. Mineral waters can therefore have potentially beneficial 
or harmfiil effects on health, including bone health.
Mineral waters are recommended in the prevention of osteoporosis, mainly 
because of their high calcium content. Calcium in mineral water lowers PTH
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and bone resorption markers [158]. Further studies have shown that high 
calcium and bicarbonate content are also beneficial [159-161].
Calcium-rich mineral waters have been shown to be an alternative to dairy 
products, as the calcium-bio-availability is similar, or possibly even better 
[162].
Nutrition has long been known to influence acid-base balance in humans 
[163], with a positive association between the consumption of alkali-forming 
foods, such as fruit and vegetables, and bone health [145]. Alkalinising 
mineral waters can also influence the acid-base equilibrium of the body [164].
In healthy subjects, the administration of potassium bicarbonates, potassium 
citrate, and even mineral water rich in bicarbonates, allowed a decrease of the 
calciuria and of bone resorption markers [123, 159, 165-166]. Mineral waters 
may consequently be an easy and inexpensive supplementary measure in the 
prevention of osteoporosis.
2.3.9 A C ID -B A SE  A N D  BO N E H EALTH  
Definition
There are two different sets of definitions:
1) The first definition was proposed by Brénsted and Lowry. They defined an 
acid as a substance that can “donate” a proton, and a base as a substance that 
can “accept” a proton. For example, HCl is considered an acid as it releases a 
H+ when it disassociates. NaOH is considered a base because, after 
disassociation into Na+ + 0H-, the hydroxyl ion can accept a proton OH- + 
H+ = H20. When an acid donates its proton, it becomes a base, because it can 
now accept a H+. When a base accepts an H+, it becomes an acid because it 
now has an H+ to donate.
2) The second definition is the “pH definition”. Aqueous solutions can have 
H+ values ranging from greater than 0.1 moles per litre to less than 
0.000000000000001 moles per litre. The pH scale expresses this wide range 
of values using base 10-logarithmic values. A one-unit change in pH 
represents a ten-fold change in H+. This “factor-of-ten” relationship means 
the pH scale is a base-10 logarithm scale. The scale goes from 1 to 14. pH 7 
is neutral when the water temperature is 25°. Thus, the neutral pH of water at 
body temperature (37°) is really 6 .8 .
An acid is defined as a substance that, when added to a solution, raises H+ 
(lowers pH). A base is defined as a substance that, when added to a solution, 
lowers H+ (raises pH). For example, HCl is an acid because it causes the pH 
of water to rise. CO2  is not an acid following the Brénsted and Lowry 
definition, because it has no H+ to donate; however, it is considered an acid in 
this second definition as it causes pH to fall when it is bubbled through water.
A strong acid is one that disassociates nearly 100% when dissolved in water. 
A weak acid, in contrast, is only partially disassociated and only some 
molecules are disassociated at any given moment.
Buffers
A buffer is a chemical substance that helps stabilise the H+ of a solution and 
consists of two parts: 1) a weak acid (HA) and 2) the conjugate base of that 
acid (A-). A buffered solution is a solution that has a buffer dissolved in it.
Buffering occurs because HA liberates free protons when H+ falls, and A- 
removes free protons when H+ rises.
Maintenance of acid-base homeostasis is tightly regulated in the extracellular 
fluid (ECF) at pH 7.4 (± 0.05). ECF has two components: 20% of blood
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plasma and 80% of interstitial fluid. Human survival requires that ECF pH 
remains between 6 . 8  and 7.8. Health, as opposed to survival, requires a much 
narrower range, usually between 7.35 and 7.45. Almost every biological 
process in the human body is dependent on the acid-base balance. Even small 
perturbations in pH can have crucial effects on cellular function.
Regulatory mechanisms of acid-base homeostasis
The maintenance of the pH in the ECF is a priority to guarantee the structure 
and function of proteins, the stability of cell membranes and the distribution of 
electrolytes. For this reason, the organism has several possibilities of 
eliminating acids that could disrupt this natural balance when acidosis is 
present.
As shown below, several organs interact in the acid-base metabolism.
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
FIG. 8 INTERACTION OF ORGANS IN A CID -BASE METABOLISM  
(From Remer T, Influence o f  diet on acid-base balance, Seminars in Dialysis,
When the organism has an excess of hydrogen ions from the diet, several 
mechanisms regulating acid-base homeostasis are employed:
- Blood pH is buffered initially by plasma proteins and the CO2-HCO 3 
system. The blood buffer capacity is determined by the combined 
effect of the groups of anions working as buffers:
52% bicarbonate buffer
15% protein buffer
2 % phosphate buffer
31% haemoglobin buffer
The bicarbonate buffer interacts directly with respiration through the 
formation of carbon dioxide, which is breathed out.
The intestine is not directly involved in acid or base generation. 
However, depending on the composition of the diet, it regulates the 
blood bicarbonate level by increasing the amount of alkali (in the form 
of pancreatic secretion) that is re-absorbed.
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FIG. 9 THE INTESTINE AS AN ACID- OR BASE-FORM ING ORGAN
An example o f the generation o f net acid as a result o f  physiologically low 
cation (Ca) absorption and an associated loss o f endogenous HC03 (from 
Remer T, Influence o f diet on acid-base balance, Seminars in Dialysis, vol 13, 
2000, ;:y?.227-22l^
Liver plays an important role as it produces large amounts of hydrogen 
and alkali ions by oxidising the absorbed sulphur-containing amino 
acids and alkali salts, and therefore contributing to the diet-derived 
acid-base pool in blood.
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FIG. 10 CONTRIBUTION OF HEPATIC M ETABOLISM  OF SULFUR-CONTAINING  
AM INO ACIDS (A A -SH ) AND  M ETABOLIZABLE ORGANIC ACIDS (O A) IN THE 
FORMATION OF ACID A N D  BASE
(From Remer T, Influence o f diet on acid-base balance, Seminars in Dialysis,
vo/ 73, 2000, j9p.227-22(^
Lungs are able to modify the blood pH within a narrow range by 
changing the rate at which CO2 is exhaled.
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Kidneys eliminate non-volatile acids that are produced endogenously 
from the diet. The kidneys are also capable of regenerating lost 
bicarbonate, thus assisting in the restoration of the circulating 
bicarbonate pool. Most importantly, the kidneys are unable to excrete 
urine lower than pH 5, and therefore other buffer systems must come 
into play to restore acid-base status in humans.
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FIG. 11 HEPATIC GENERATION, INTERM EDIARY BUFFERING, A ND  RENAL  
EXCRETION OF ACID EQUIVALENTS
(From Remer T, Influence o f  diet on acid-base balance, Seminars in Dialysis,
vo/ 73, 2000, ;: .^227-22di)
Bone plays a significant role in acid-base homeostasis, as it is able to 
contribute alkaline buffering mineral salts. Potassium and chloride are 
confined to the hydration shell and are most rapidly and completely 
exchangeable. Magnesium, sodium, citrate and carbonate can 
penetrate the surface of the crystal lattice and are less exchangeable.
Finally, calcium and phosphate (PO4) can penetrate the crystal interior 
and are exchangeable, but exceedingly slowly. However, over time, 
this process will lead to the dissolution of the bone mineral content, 
and hence a reduction in bone mass [120, 167-168].
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FIG. 12 SCHEMATIC OF EFFECTS OF M ETABOLIC ACIDOSIS ON BONE
(From Bushinsky A and Frick K, The effects o f acid on bone,2000, Curr Opin
NephrolHypertens 9:369-379.)
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Importance of the acid-base homeostasis
Disturbances of acid-base balance in the body are classified as either acidosis 
(leading to an acid environment and indicating an excess of ions), or 
alkalosis (leading to a reduction in ions and therefore a more alkaline 
environment). Such disturbances of acid-base balance are also relevant to 
bone health. In vitro studies have shown that there is an induced calcium 
efflux from bone due to metabolic-acidosis [169]. A moderate increase in 
alkaline equivalents has been shown to reduce bone resorption, increase bone 
formation, and improve calcium balance in post-menopausal women [166].
Nutritional factors which influence acid-base balance
Nutrition has long been known to strongly influence acid-base balance in 
humans [163]. Intakes of potassium, magnesium, and fruit and vegetables 
have been associated with a more alkaline environment in the human body, 
therefore having a beneficial effect with regard to bone health [145].
Protein is an important macro-nutrient contributing to BMD; however, it has 
an acidic effect on bone, which is thought to be undesirable. More precisely, 
two mechanisms come into play; the protein excess induces an increase in the 
renal calcium excretion and the metabolism of the sulphur amino acids 
(methionine and cysteine) generates an acid load, which results in a reduction 
of blood and urinary pH [117, 120, 170].
Bushinsky and colleagues have demonstrated that the acidification of bone 
may not be linked only to osteoclastic activity. They have shown that cultured 
osteoblasts show reduced collagen synthesis and mineralisation in an acidic 
environment [171-172].
Furthermore, other studies conducted in both animal and human models have 
demonstrated that an acid environment is associated with a negative calcium 
balance and increased bone loss [173-175]. On the other hand, a number of 
studies have demonstrated a positive association between the consumption of 
alkali-forming foods, such as fruit and vegetables, and bone health [145].
Dietary intake
Each day, humans consume food which, once metabolised, generates or 
consumes H+ (diagram below). It has been estimated that the typical 
Westernised diet consumed by adults generates ~ 50 mEq acid/d. Therefore, 
healthy adults consuming such a diet are at risk of chronic, low grade 
metabolic acidosis, which worsens with age due to a decline in kidney 
function [117].
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FIG. 13 M ETABOLISATION OF H+
(from Remer T, Influence o f diet on acid-base balance, Seminars in Dialysis,
AO
This typical. Western diet could result in the heavy usage of buffer salts found 
in the bone, leading to lower bone mass and osteoporosis.
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FIG. 14 HYPOTHESIS FOR THE M ECHANISM S LEADING TO DIETARY ACID- 
INDUCED INCREASED BONE RESORPTION AND DECREASED BONE FORM ATION
[1]
(from Bushinsky A and Frick K, The effects o f  acid on bone,2000, Curr Opin 
Nephrol Hypertens 9:369-379.)
Measuring acid-base content of food
During the past few decades, a number of researchers have used in vitro 
methods, which are inappropriate to specifically determine the acid or alkaline 
producing potential of the diet [176]. Frassetto and colleagues have estimated 
the net endogenous, non-carbonic acid production (NEAP) from the diets of 
normal adults. This is another method used to measure the acid-base ratio, 
which is based on the dietary protein to potassium ratio in normal diets [177]. 
This method has limitations when estimating the acid-base ratio of whole 
diets, because it does not take into account the absorption rates of these 
nutrients.
Estimated NEAP (mEq/d) =
[54.5 X protein (g/d) / potassium (mEq/d)] -1 0 .2
Therefore, a more accurate in vitro measurement of the acid-base ratio has 
been determined using a calculation model, developed by Remer and Manz 
[178-179], They have estimated the net acid load from average intestinal 
absorption rates of ingested protein and minerals, as well as an anthropometry- 
based estimate for organic acid excretion.
Estimated NEAP: PRAL (mEq/d) + OAest (mEq/d) [180]
Where PRAL denotes potential renal acid load and OAest denotes estimated 
urinary organic anions, the two components are calculated as follows;
PRAL (mEq/d) =
0.49 X protein (g/d) + 0.037 x phosphorus (mg/d) -  0.021 x potassium 
(mg/d) -  0.026 X magnesium (mg/d) -  0.013 x calcium (mg/d)
OAest (mEq/d) =
individual body surface area [0.007184 -  height (cm) -  weight (kg)
0.425
] X  41/ 1.73
A practical and useful method, when assessing the role of the skeleton in acid- 
base homeostasis, is to determine the acid-base ratio of foods which contribute 
to the overall diet consumed by individuals and population groups [181].
Remer & Manz have estimated PRAL in a variety of foods items using the 
nutrient data per lOOg of food for protein (methionine, cystine), P, Cl, K, Mg, 
calcium, and Na.
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FIG. 15 POTENIAL RENAL ACID LOAD (PRAL) V ALUES OF A VARIETY OF FOODS
A ND  FOOD GROUPS
(Taken from Remer &. Manz, 1995).
(Negative PRAL values: Positive effect on bone health. Positive PRAL 
values: Negative effect on bone health)
There have been a lot of studies looking at the health-related benefit of a high 
consumption of fruit and vegetables in the prevention of a variety of diseases, 
including osteoporosis. A diet rich in fruit and vegetables may provide 
protection against major chronic diseases such as cardiovascular disease [182], 
several common cancers, hypertension [183] and bone health [145].
Jones and colleagues found that urinary potassium (marker for dietary 
potassium and fruits and vegetables) was positively associated with BMD at 
the lumbar spine, femoral neck and total body in 330 boys and girls (aged 8 
years). Children in the highest quartile of urinary potassium had higher BMD
at three distinct sites compared to the children in the lowest quartile (femoral 
neck. Furthermore and more importantly, urinary potassium correlated 
significantly with potassium intake, and fruit and vegetable intake [134]. 
Tylvasky and colleagues (2004) showed that adolescent girls who reported 
consuming fruit and vegetables >3 times a day had, when compared with 
similar girls who reported consuming fruit and vegetables <3 times a day, 
lower urinary calcium excretion, lower PTH concentrations, and larger bone 
size as indicated by bone area of the whole body and of the non-dominant 
wrist after controlling for age, BMI, and physical activity [184]. Studies 
conducted in pre-menopausal women have also shown positive results with 
regard to higher intakes of potassium, fruit and vegetables on bone health 
[144, 185]
2.4 Nutritional assessment and epidemiology
Assessment of dietary intake in specific populations is a critical component 
when determining the effect of nutritional factors on specific health issues
[186]. With the help of computer technology, nutritional assessment tools to 
study the relationship between diet and bone health have progressed 
significantly and very large amounts of data can be handled. When assessing 
dietary intake in population studies, it is also important to collect 
anthropometric and clinical data at the same time (i.e. age, weight, physical 
activity, etc.). There are numerous tools available to assess diet.
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I. 24-hour recall
The 24hour recall can be undertaken face-to-face or by phone. The interviewer 
obtains information on all foods and beverages consumed during the last 24 
hours (from midnight to midnight). Only 1 day is represented by this method 
but if multiple recalls are undertaken, the variability for most nutrients 
decreases. This method is used for assessing nutrient intake of the population 
and not the individual. It is easy to use, although variations, such as weekends 
or holidays for example, have to be avoided. This method can be difficult to 
use in the elderly due to memory loss [186-188].
II. Dietary record (weighed or not)
Dietary records must be completed by the subject, who writes down all foods 
and beverages consumed. Intake can be assessed from 1 to 10 days, running 
either continuously or intermittently over a longer period. The record can be 
weighed, which implicates that the subject weighs everything eaten or drunk, 
using scales. Each subject needs to be trained by a dietician before completing 
the record. Precise advice on the quantity and quality of the food is critical to 
obtain sufficiently detailed data for input into the software. This method is 
very time consuming for the subjects. Also, subjects can be tempted to change 
their eating habits to simplify the record completion [186-188].
III. Food frequency questionnaires
(Qualitative, semi-quantitative and quantitative)
The principle of FFQ is based on the knowledge that dietary intake over 
weeks, months or years is particularly important for chronic diseases, such as 
osteoporosis. A FFQ has at least two components, being a food list and a
A'7
frequency option, to assess how often each food was eaten. A notion of 
weight, or size of portion, can also be added.
For the assessment of average long-term dietary intake in large numbers of 
individuals, FFQ have emerged as particularly useful tools, since they give a 
better approximation of usual, long-term dietary intake rather than short-term 
records, they can be self-administered and are relatively inexpensive to use. 
Prior to their use in studies, FFQs need to be adapted to the typical food 
consumption of the population under investigation [189]. A valid and reliable 
FFQ can be self-administered and analysed using a computer program, and can 
enable large epidemiological studies assessing nutrient intake and its relation to 
disease. It can also be useful for public health and clinical counselling. Short­
term recalls and diet records are expensive and unrepresentative of usual intake 
if only a few days are assessed, and inappropriate for assessment of past diet
[187].
Besides children and adolescents, the population of interest is often the 
elderly. However, few studies have assessed the use and validity of dietary 
assessment methods in the elderly, particularly those classified in the oldest 
group (75 years plus). Furthermore, FFQs are the method that have been used 
most frequently in studies on bone health and nutrition [188]. There is no 
evidence that the elderly population has greater difficulty - compared to the 
younger subjects - when faced with dietary intake assessment methods. 
However, most studies performed in the elderly have been undertaken in 
healthy, non-institutionalised subjects [190]. Before being used, the FFQ needs 
to be tested for validation and reproducibility.
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The validation study consists of comparing individual values from the FFQ, 
with an independent and more accurate measure of diet. It assesses the level of 
agreement between dietary intakes using another method of dietary assessment. 
Reproducibility is the ability of an instrument to produce the same estimate on 
two different occasions, assuming nothing has changed over the intervening 
period. It does not prove anything about whether the instrument is producing 
the correct answer, only whether it is producing the same answer [191].
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3. EVANIBUS STUDY -  M ETHODOLOGY  
(EVAluation of Nutrients Intakes and Bone Ultra Sound) 
3.1 General introduction
Very few investigations have been conducted specifically to examine the 
association between nutrient intake, acid load and bone ultra-sound in the aging 
Swiss population. The EVANIBUS (EVAluation of Nutrient Intake and Bone 
Ultra Sound) study on osteoporosis in an elderly, Swiss population, examined the 
influence of dietary intake on bone health indices, in a cohort of 401 ambulatory 
women from the Lausanne area, an urban agglomeration of about 200,000 
inhabitants in the Canton ofVaud, Switzerland.
In this Thesis, the EVANIBUS study is presented as 3 sub-group studies:
1. FFQ Development study
2. Energy and nutrient intake of Swiss women aged 75 to 87 years
3. Low estimates of dietary acid load are positively associated with bone 
ultrasound in women older than 75 years with a lifetime fracture
Firstly, however, the EVANIBUS study is presented in general.
3.2 General aims and objectives
The EVANIBUS study aims:
I) To develop and validate a FFQ capable of assessing food nutrient intakes 
over a time period of a year in an elderly, Swiss population living in the 
French-speaking part of Switzerland.
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2) To create a computer programme capable of calculating the FFQ
3) To assess the nutrient intake and dietary patterns of these elderly Swiss
women
4) To investigate dietary and nutritional influences on bone health in this
elderly, Swiss population.
Specific objectives:
• Is poor macro and micronutrient intake associated with lower calcaneal 
bone mass (as measured by ultrasound attenuation)?
• Is a high estimate of dietary acidity associated with an increase in 
fracture risk?
• Is poor dietary quality associated with lower bone health and higher 
fracture risk, between bone health indices measured bone ultra-sound 
and nutrient intake measured by the FFQ?
Hypothesis
The hypotheses to be tested are that:
• poor macro and micronutrient intake is associated with lower calcaneal 
bone mass.
• a high estimate of dietary acidity is associated with an increase in 
fracture risk.
• poor dietary quality is associated with lower bone health and higher 
fracture risk between bone health indices measured by bone ultra­
sound and nutrient intake measured by the FFQ.
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3.3 General methodology 
Ethics approval
The study was approved by the University of Lausanne’s Ethical Committee 
(Appendix 8). Informed and signed consent was obtained from each subject, 
prior to investigation.
Subject recruitment
Patients were recmited from the cohort of The Swiss Evaluation of the Methods 
of Measurements of Osteoporotic Fracture Risk (SEMOF). SEMOF was a 
multicentre cohort study, which compared three quantitative ultrasounds (QUS) 
for the assessment of hip fracture risk in a sample of 7609 elderly, ambulatory 
women > 70 years of age. Between November 1997 and August 1999, 7609 
women were recmited from official state registries and asked to visit 1 of the 10 
major Swiss osteoporosis centres certified to use the three QUS devices 
available. 808 women took part in the SEMOF study in the Lausanne centre. 
By 2002, 760 women finished the SEMOF study. Forty-eight women had died, 
moved, or become too ill to continue participation in the study. The study ended 
in 2002 and all 760 women from the Lausanne Osteoporosis Centre were 
contacted by phone in order to ascertain whether they would like to take part in 
the EVANIBUS study. 549 women were interested in participating in the 
EVANIBUS study and when it began in 2003, the final number of participants 
was 401. From the initial 549 women, another 148 women were sadly lost for 
follow-up because of death, illness or simply because they changed their minds.
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FIG. 16 EVA NIBU S STUDY DESIGN  
Inclusion and exclusion criteria
The inclusion criterion was having participated in the SEMOF study. 
Furthermore, only patients with a good written and oral comprehension of 
French and with no cognitive impairment were included.
The SEMOF study inclusion and exclusion criteria were:
Inclusion criteria: Women able to walk and independent for daily activities.
Exclusion criteria:
• Hip fracture history or bilateral hip replacement.
• Coronary heart disease or has a pacemaker in situ.
• Known Type 1 or Type 2 diabetes.
• Renal failure or evidence of renal impairment.
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• Liver disease.
• Aeute gout.
• Obesity of known cause e.g. Cushing’s disease.
• Uncontrolled thyroid disease or an abnormal TSH level based on GP 
opinion.
• Respiratory disease (except stable asthma).
• Are currently being treated for a malignancy.
• Are suffering from rheumatoid arthritis.
• Are taking glucocorticoids.
Naturally, since their recruitment in 1997, a hip fracture may have occurred, but this was 
not considered as an exclusion criteria for EVANIBUS.
Measurements
Weight
Subjects were weighed in light clothes, (without shoes) to the nearest 0.1 kg 
using stand-on scales. The same scales were used throughout the study.
Height
Height was measured, (without shoes), to the nearest 0.5 cm using a wall- 
mounted statiometer. BMI was calculated from the above measures (weight 
[kg]/ height  ^[m]).
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Medical history
The medical questionnaire, conducted by personal interview, included 
questions on medication, fracture history, osteoporosis treatment and medical 
history.
Mini Nutritional Assessment (MNA)
The MNA was applied to each participant. The MNA test is a simple, 
validated screening tool for malnutrition in elderly people and is recommended 
for early detection of risk of malnutrition. It is an 18-item questionnaire 
comprising anthropometric measurements (BMI, mid-arm and calf 
circumference, and weight loss), combined with a questionnaire regarding 
dietary intake (number of meals consumed, food and fluid intake, and feeding 
autonomy), a global assessment (lifestyle, medication, mobility, presence of 
acute stress, and presence of dementia or depression), and self-assessment 
(self-perception of health and nutrition). The MNA classifies the nutritional 
status in three groups: <17: Malnourished, >17 and < 24: At risk of 
malnutrition, >24: Well-nourished, with a maximum of 30 points. The MNA 
is well validated and correlated highly with clinical assessment and objective 
indicators of nutritional status (albumin level, BMI, energy intake, and vitamin 
status). A low MNA score can predict hospital-stay outcomes in older patients 
and can be used to follow changes in nutritional status. In more than 10,000 
elderly people, the prevalence of under-nutrition assessed by the MNA is 1% 
to 5% in ambulatory patients, 20% in hospitalised patients, and 37% in 
institutionalised, elderly patients. Several studies have looked at the 
relationship between MNA scores and bone health. Gerber et al  showed a 
trend for a correlation between the MNA and the ultrasound parameter BUA 
(r=0.207, P=0.07) in 78 institutionalised women aged 86 years + 6 years.
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Furthermore, Salminen et al. investigated the relationship between 
osteoporosis and the MNA in 351 elderly, independent women. Half of the 
women who displayed an MNA score <27, had a twofold increased risk of 
having osteoporosis.
Quantitative Ultrasound (QUS)
QUS was applied to each subject at the calcaneus, the only validated site. As 
already described in the literature review, the Ultrasounds are sound waved 
beyond the audible threshold, defined as 20 kilo hertz (kHz). The mechanical 
and physical properties of bone progressively alter the shape, intensity and 
speed of the propagating wave. Bone tissue is therefore characterised in terms 
of ultrasound velocity and attenuation. There are differences in the calculation 
of these parameters between the different manufacturers and models [43].
The QUS Achilles PLUS, GE-Lunar, Madison, WI, USA, S/N 9056, August 15, 
1995 equipment was used, which expressed the results as follows. For 
clarification and standardisation purposes amongst the different heel QUS 
devices, the 2007 ISCD Official Positions’ Expert Panel, rated the following as 
appropriate terminology [43]:
- Broadband Ultrasound Attenuation (BUA), in dB/MHz, is the 
recommended attenuation parameter.
Speed of sound (SOS), in metres per second (m/s), is the recommended 
velocity parameter.
- A composite parameter combining BUA and SOS, such as Stiffness 
Index (SI).
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Potential advantages of QUS, compared with measurement of BMD, include 
lower expense, portability, and lack of radiation exposure. Measurements are 
most commonly made at the calcaneus, which is the only validated site. QUS is 
a good predictor of osteoporotic fracture risk in postmenopausal women and 
men over the age of 65.
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4. FFQ DEVELOPMENT STUDY
4.1 Introduction
Research indicated that there are no dietary methodologies such as Food 
frequency questionnaires (FFQ) for elderly populations within 
Switzerland, and hence it was considered imperative to develop a Swiss 
FFQ. The FFQ was developed to investigate diet in its entirety, rather 
than just looking at nutrients specific to bone. Nonetheless, since the 
EVANIBUS study is specific to osteoporosis, particular interest was paid 
to the intake of nutrients known to affect bone health. Several 
questionnaires exist assessing dietary patterns or frequency consumption 
of food groups, but no tool is currently available to assess the actual 
different nutrients in the elderly population, in relation to bone health 
[192-193].
4.2 Methods
In order to develop the FFQ with a sample of the studied population, dietary 
intake was assessed in a sub-group of 51 women (mean age 82 years, mean 
BMI 23.1 kg/m^).
They were asked to complete a 4 day weighed record (WR) (3 continuous 
week days and 1 week-end day; 4d WR Appendix 1). The data collection 
period was from summer through to autumn in 2002. A dietician advised each 
woman prior to starting the weighed record, and regular contact was made 
during and after the recording period, to ensure compliance and competency. 
Each woman received a brochure explaining how to complete the WR 
(Appendix 2). The women were asked to write everything they drank and ate,
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by estimating their portion sizes using common household measures such as 
bowls, spoons, etc. The women could also use their personal domestic scales. 
They were asked to write down the time and location, as well as the type of 
food and beverage consumed, as precisely as possible. The dietician then 
collected the WRs during the women’s visit to the hospital and checked for 
completion. The food portion sizes were estimated using a French food and 
beverage photo manual, when the women had forgotten to write down the 
quantity [194]. The diet records were then coded and entered using a 
computer nutrition analysis package (Appendix 6) [195]. This package 
contains German, Austrian and French food composition tables because, at the 
time of the study, the first Swiss food-composition table was not available for 
use [196]
4.2.1 SELECTIO N OF FO OD L IS T  TO BE INCLUD ED I N  THE  
FFQ
The FFQ food list was elaborated with the most commonly consumed foods in 
the WR. Some exceptions were made for foods not appearing in the WR, 
mainly because the WRs were completed from summer through to autumn. 
Several typical, Swiss winter dishes (Fondue and Raclette for example, dishes 
made with cooked cheese) were added to the food list. The FFQ did not allow 
subjects to provide information about foods not included in the food list.
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31 food items consumed in the WR were not used in the FFQ (see table 2). 
Indeed, they were either only consumed once, or did not have any impact on 
the nutritional intake (vinegar for example), or could be put under another 
category of foods (eg. plums, which were quite frequently consumed, could be 
put under peaches and apricots).
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Table 2 List of foods appearing in the Weighed Records but not
used in the FFQ
Food Number of times
1. Fruit nectar 2
2. Avocado 4
3. Chocolate bar 4
4. Cereal bar 2
5. Peanut butter 4
6. Vegetable broth 4
7. Meat broth 6
8. Chestnuts 1
9. Sauerkraut (fermented cabbage) 1
10. Palm tree heart (tinned vegetable) 1
11. Cordon bleu (pork, ham & cheese fried in 1bread crumbs)
12. Chestnut purée 4
13. Dates 1
14. Flour 3
15. Figs (fresh) 5
16. Meringue 1
17. Mirabelle (sort of plum) 5
18. Fish mousse 3
19. Mustard 6
20. Olives 4
21. Nettles (for a nettle soup!) 1
22. Paella 1
23. Gingerbread 1
24. Cenovis (kind of Swiss Marmite) 6
25. Pois mange-tout 1
26. Plums 33
27. Ratatouille 5
28. Reine-Claude (sort of plum) 8
29. Cheese tart 4
30. Vinegar 30
31. Sauces (cream, wine etc) 15
The food list was created by using the food items most frequently consumed 
in the WR. Food items with similar nutrient content were grouped together. 
For example, green vegetables were grouped together as one food item.
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To determine the FFQ food list, the percentage contribution of food items as 
sources of bone health nutrients, including protein, calcium, phosphorus, 
potassium and vitamin D were calculated, alongwith total energy intake and 
fat.
As shown in Table 3 below, the food group which contributed most 
importantly to calcium (53.1%), energy (17.1%) and phosphorus (31.2%) 
was milk and dairy products. Meat, fish and eggs were found to be the main 
foods contributing to the total protein (29.5%) and vitamin D intake (72.5%). 
The majority of potassium intake was from fruit and vegetables (36.6%). 
The food list used in the FFQ accounted for 95% of the total energy intake of 
the WRs, and contributed by a minimum of 85% to the nutrients of major 
interest for bone health, which had been consumed by the studied population.
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The FFQ was then tested in a pilot study on 10 women. The subject’s 
perceptions of the meaning of the questions was looked at when personal 
contact was made with each woman. Wording for several questions was 
improved [197]. The size of the typeface used was increased for easier 
reading by the elderly population. The final FFQ included 110 food items. 
Although this may seem long for the elderly, it has been demonstrated that 
shorter FFQs are no better than longer FFQs in terms of the response rate and 
the quality of the data [198]. The sequence of questions was in chronological 
order, starting with breakfast foods.
4.2.2 D E T E R M IN A T IO N  OF S T A N D A R D  FO OD P O R T I O N  
SIZES
At first, food portions of the WRs were also used, as Switzerland does not 
have standard food portions. For each food consumed in the WR, the mean 
portion was calculated and then used as the portion in the FFQ, in order to 
allow for the calculation of the nutritional value of a standard portion. The 
food portions were adapted when only one portion size was available and 
seemed particularly low or high. The first food portions used were too high 
and the FFQ was therefore over-estimating the quantities compared to the 
WR. Consequently, the food portions were revised for the first time; 
however, the FFQ was still over-estimating the quantities and the FFQ food 
portions were therefore revised a second time, after which a good agreement 
was found between the FFQ and WR results. This is shown in Table 4 
below.
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4.2.3 FREQ U EN CY O P T IO N S
In order to allow the four seasons to be represented in the responses, the 
timeframe of the FFQ was the previous 12 months. Earlier studies in elderly 
subjects were investigated and the one considered most appropriate for use in 
the older population group was piloted and used in the final version [197, 
199].
The 9 fi-equency options used varied from never/less than once a month, to 6 
times a day or more.
They were:
1. Never/less than once per month
2. 1 to 3 times per month
3. Once per week
4. 2 to 4 times per week
5. 5 to 6 times per week
6. Once per day
7. Twice per day
8. 4 to 5 times per day
9. More than 6 times per day
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4.2.4 C O M P U T E R IS A T IO N  OF THE FFQ
An IT specialist, David Whittamore, studying at the University of Surrey 
created an Access file to process the data from the study’s FFQ (Appendix 
3). He entered into the Processing programme:
1) All the portion sizes
2) The mean energy and nutrient intake per lOOg of each food item or 
food group (Appendix 5)
3) The frequency options as shown below
Table 5 Portions per time period
Respondent choice Weekly value Daily value
Never or less than once per month 0 0
1-3 per month 0.5 0.07
Once a week 1 0.14
2-4 per week 3 0.43
5-6 per week 5.5 0.79
Once a day 7 1
2 per day 14 2
4-5 per day 31.5 4.5
6+ per day 42 6
Algorithms were then created.
For example:
If given the question, “At what frequency do you usually eat root vegetables 
(such as carrots, roots, turnips, beetroot or celeriac)”, the subject responded 
2-4 times/per week (=3/7 per day), values were calculated accordingly:
i) The portion size in the FFQ for root vegetables is lOOg.
9 2
ii) The computer programme would multiply the portion size (lOOg), by the 
frequency (3/7=0.43) and finally, by the mean energy and nutrient intake of 
this food group.
The data entry of each FFQ takes approximately 20 minutes and the 
Processing programme was then capable of immediately calculating the 
mean daily energy and nutrient intake for each subject.
4.3 FFQ Validation study
The validation study consisted of comparing individual values from the FFQ, 
with an independent and more accurate measure of diet (WR in the present 
study). The FFQ was validated in a randomly selected sub-group of 51 
women, who completed the 4 d weighed record (WR). Prior to their visit, 
each woman received the FFQ by post, then completed it at home and 
brought it back to the hospital at the time of their appointment. After one 
reminder phone call, 44 of the 51 FFQs were returned.
A dietician discussed each FFQ with the respondent and questioned any 
missing answers, which were subsequently completed.
44 subjects participated in the validation study, 14 in the short-term 
reproducibility study, and 15 in the long-term reproducibility study. Age, 
weight and height were similar between the groups and there were no other 
significant differences.
9 3
4.4 FFQ Short-term reproducibility Study
Reproducibility is the ability of an instrument to produce the same estimate 
on two different occasions, assuming nothing has changed over the 
intervening period. Its use is not intended to prove whether the instrument is 
producing the correct answer, only whether it is producing the same answer 
[191].
A total of 25 women were asked if they would complete the same FFQ, one 
month later. Sixteen women accepted and received an identical FFQ with a 
pre-stamped, addressed envelope during their medical visit, for completion a 
month later. One FFQ was rejected as it had been completed incorrectly.
4.5 FFQ Long-term reproducibility Study
Approximately 12 months after their visit to the hospital, a total of 21 women 
were sent a covering letter, and a second and identical FFQ, with a pre­
stamped, addressed envelope. Sixteen agreed to answer. Two FFQs were 
rejected as they had been completed incorrectly.
4.6 Statistical analysis
All analyses were performed by using the SPSS statistical software package 
(version 12.0, Chicago). Normality was tested by Kolmogorov-Smimov. 
All nutrients not normally distributed were logged to the natural transformed 
[200-202]. The validation analysis compared the FFQ with the WR results. 
Pearson correlations were used, as well as paired t-tests, and all nutrients 
were energy-adjusted [187].
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The women were classified into fifths of nutrient intake for the FFQ and the 
WR for the validation study, and for the initial and repeat FFQ in short (ST) 
and long-term (LT) reproducibility studies.
It was then questioned as to whether it was appropriate to divide a group of 
44 subjects into quintiles -  thirds seemed more reasonable - both results are 
therefore presented. The percentage of nutrient intake, correctly classified 
into quintiles, was calculated. Bland and Altman plots were also used [203].
4.7 Results
4.7.1 FFQ V A L ID A T IO N  STU D Y  
Table 6 Characteristics of elderly women included in the study
Characteristics of the elderly women included in the study (n= 401), 
including a sub-group (n=51) of women who filled in the WR
Age (years) 80.4 (±2.99) 75-87
Height (cm) 158.1 (±5.97) 142-174
Weight (kg) 62.7 (±11.3) 35-107
BMI (k g V ) 25.2 (±4.4) 15.8-40.4
4d WR N=51
Age (years) 82.04 (±2.53) 75-85
Height (cm) 157.4 (±5.73) 147-166
Weight (kg) 60.7 (±13.13) 35-107
BMI (kgW ) 23.1 (±4.6) 14.4-37.3
Mean (SD) values for energy and nutrient intake in the two methods (WR 
and FFQ) were calculated and results are shown in Table 7. The FFQ 
tended to give higher values for energy, protein, fat, carbohydrate, iron, 
calcium, phosphorus, potassium, cholesterol, magnesium, vitamin B2, B9, 
B12 and D. However, lower values were found for saturated fatty acid, 
fibre, sodium, zinc, manganese, vitamin C, E and K, together with retinol
9 5
equivalent. Intakes of vitamin A, B1 and B6 were identical between the 
WR and FFQ. Nutrients were normally distributed except for fat, calcium, 
fibre, sodium, cholesterol, magnesium, manganese, vitamin A, B l, B2, B6, 
B9, B12, D, E and K. These were logged to the natural transformed. No 
significant differences were found between the two methods (paired t-test 
p<0.05), except for Zinc (p<0.001). The mean energy equivalent was 1.29 
for the 4 d WR and 1.37 for the FFQ. The average p-value was 0.41. It 
ranged from 0.0001 for zinc to 0.65 for saturated fatty acid.
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The average Pearson correlation co-efficient was 0.358 for crude nutrient 
intake and 0.392 for energy adjusted nutrients. It ranged from 0.025 for 
crude vitamin A intake to 0.655 for crude vitamin B9 intake. The Pearson 
co-efficient correlation ranged from 0.010 for vitamin A energy-adjusted to 
0.643 for magnesium energy adjusted intake (Table 8).
The classification of the nutrient intake into thirds showed an average of 
‘correctly classified’ at 65% and into fifths, an average of ‘correctly 
classified’ at over 31.3% (Tables 9 & 10 overleaf).
9 9
O'
1
I
I
i(+40
1  «  
I
g
o
§
%
w
1/3(/3cd
U
ON
O
H
oo
CN
CN
cn
CNm»nCN cncn cnCN cncn CNcn cn cn cn cn
CN 3 3 oooo\o O su~i Oscn oocn cn
CN i 0?: ^  ^ •sD CN cn I cn I Osi cn ooo cncn
-  ^  SCNcn cn Oncn ocn»nCN CNcnCN cn I cn I I cnCN
CN
o i
Ml'OoC/D
OO
Table 10 Classification of women into thirds of nutrient intake
for the 4d WR and FFQ
Validation
% (n) correctly classified
Energy 48 (21)
Protein 41 (18)
Fat 41 (18)
Carbohydrate 48 (21)
Fibre 48 (21)
Calcium 41 (18)
Iron 57 (25)
Phosphorus 50 (22)
Potassium 55 (24)
Magnesium 57(25)
Vitamin B 12 39 (17)
Vitamin C 57 (25)
Vitamin D 39(17)
Vitamin K 43 (19)
Bland and Altman plots were made for the crude nutrient intake (Figs. 17, 
18 & 19). These plot the difference between the methods against their mea 
mean and allow for investigation into any possible relationship between the 
measurement error and the true value [204].
FIG. 17 BLAND A ND  ALTM AN PLOT FOR ENERGY INTAKE IN THE VALIDATIO N
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FIG. 18 BLAND A ND  ALTM AN PLOT FOR CALCIUM INTAKE  
IN THE VALIDATIO N STUDY
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FIG. 19 BLA N D  AND ALTM AN PLOT FOR VITAM IN C INTAKE IN THE
VALIDATIO N STUDY
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However, calculation of differences for all nutrient intakes between the two 
methods found the mean value to be close to zero for the majority of nutrients. 
More than 95% of the values were within 2SD above, or below, this value. 
For most nutrient intakes, the FFQ tended to over-estimate intakes and thus, 
the majority of women were found to be distributed below the difference, as 
shown in Figures 17 to 19.
4.7.2 FFQ S H O R T -T E R M  R E P R O D U C IB IL IT Y
The second FFQ tended to give higher values than the first. Mean (SD) values 
for energy and nutrient intake for both FFQs, (FFQl and FFQ2), were 
calculated and results are shown in Table 11. The FFQ2 tended to give higher 
values for energy, protein, fat, saturated fatty acid, mono-unsaturated fatty acid, 
polyunsaturated fatty acid, phosphorus, sodium, potassium, zinc, cholesterol, 
magnesium, iodine, vitamin B2, B9, B12, C, D, E, K, retinol equivalent and 
alcohol. However, lower values were found for carbohydrates, fibre, calcium 
and manganese. Intakes of iron, vitamin A, B l and B6 were identical between 
FFQl and FFQ2. Nutrients were normally distributed except for calcium, 
sodium, zinc, manganese, vitamin B l, B2, B9, B12 and D. They were logged 
to the natural transformed. No significant differences were found between the 
two methods (paired t-test p<0.05). The average p-value was 0.41. It ranged 
from 0.0001 for zinc to 0.65 for saturated fatty acid.
The average Pearson correlation co-efficient was 0.744 for crude nutrient 
intake and 0.791 for energy-adjusted nutrients. It ranged from 0.444 for crude 
calcium intake to 0.944 for crude vitamin A; and from 0.570 for phosphorus 
energy adjusted to 0.926 for vitamin B9 energy adjusted intake (Table 12). The 
classification of the nutrient intake into thirds showed an average of ‘correctly 
classified’ at 65% and into fifths, an average of ‘correctly classified’ at 50% 
(Tables 13 & 14).
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Table 11 Comparison of nutrient intake as measured by initial (FFQl) and 
repeat FFQ in short-term (ST) reproducibility study
ST reproducibility (n=15)
Nutrient FF< FFI52
Mean SD Mean SD
Energy (kcal) 1387.3 309.8 1425.2 317.5
Protein (g) 56.7 14 59.4 15.1
Fat (g) 59.2 14.6 63.1 19.4
Saturated fatty aeid (g) 21.6 5.7 22.5 6.1
Mono-unsaturated fatty acid (g) 20.4 4.9 21.9 7.2
Poly-unsaturated fatty aeid (g) 8.6 3.2 9.5 5
Carbohydrate (g) 147.5 47.8 144.1 44.4
Fibre (g) 15.5 6.7 15 5.9
Calcium (mg) 894.6 233.4 979.8 271.2
Iron (mg) 10 3.2 10 2.4
Phosphorus (mg) 1061.3 283.7 1115.5 301.1
Sodium (mg) 1346.1 389.9 1383.5 399
Potassium (mg) 2370.4 593.1 2428.4 564.6
Zinc (|ig) 4.8 1.3 4.9 1.4
Cholesterol (mg) 259.7 59.4 264.7 63.8
Magnesium (mg) 265.6 87.6 265.8 72.8
Manganese (mg) 2050.7 937.5 2044.9 758.6
Vitamin A (gg) 0.5 0.3 0.5 0.3
Vitamin Bl (gg) 0.9 0.4 0.9 0.6
Vitamin B2 (gg) 1.3 0.4 1.4 0.4
Vitamin B6 (gg) 1.1 0.3 1.1 0.3
Vitamin B9 (gg) 191.2 95 194.3 86.6
Vitamin B12 (gg) 4.2 1.3 4.4 1.6
Vitamin C (gg) 2.2 0.8 2.3 1
Vitamin D (gg) 64.9 22.2 66 19.9
Vitamin E (gg) 8.2 2.8 8.6 3.3
Vitamin K (gg) 257.9 99.4 283.2 128.6
Retinol equivalent (gg) 999.7 441.9 1074.4 441.4
Alcohol (g) 4.4 3.7 5.1 4.1
Water (ml) 2016.9 498.1 2021 446.7
By paired t-test; all non-significant
i n a
Onm
oo
oo m
CN
o
CN Oncn oo
cn
00
in
00
oo
cn
ON
OO
o
oo I oo I NOoo oo
o
oo in
oo o
NO
cn
oo
o
8cn cn
cn oo
CNin On I
O
i NO
I On ! CN I «—INO| r- i ONi OO 
o i d  d  o
NO
cnin
oo
cn
oo
s
oo
CN oo
ooin CNooNO cn00NO
d
oo oo oo
o o
73
•g. 0D|
73O
C/D00
inc
I!/3
I
IH
CO
Î
■S
O'
g
&
I
<u■s
I
§
14-(0
1  
«
I
sIq-i0 
§
1 
«
c3
o
cn
g
CN CN CN OCN CNcn cnoo
cn cno\ cnos cno\ m m m m mos m cnO s cnO sOO00 00 00 oo 00 oo oo 00
o oOsoo 00 oo
ocncn cncn cn»n cncnCN
1 1
CN
I
> |> >  >
VCc
Table 14 Classification of women into thirds of nutrient intake 
for the initial and repeat FFQ in short term (ST) reproducibility
study
ST Reproducibility
Nutrient % (n) correctly classifîed
Energy 93 (14)
Protein 67 (10)
Fat 53 (8)
Carbohydrate 80(12)
Fibre 73 (11)
Calcium 47(7)
Iron 67 (10)
Phosphorus 67 (10)
Potassium 53 (8)
Magnesium 67(10)
Vitamin B12 60 (9)
Vitamin C 67 (10)
Vitamin D 60 (9)
Vitamin K 60 (9)
4.7.3 L O N G -T E R M  R E P R O D U C IB IL IT Y
The second FFQ tended to give lower values than the first.
Mean (SD) values for energy and nutrient intake for both FFQs (FFQl and 
FFQ2) were calculated and results are shown in Table 15. The FFQ2 tended 
to give higher values for sodium, cholesterol, vitamin B12 and alcohol. 
However, lower values were found for energy, fat, saturated fatty acid, 
mono-unsaturated fatty acid, poly-unsaturated fatty acid, carbohydrates, 
fibre, calcium, iron, phosphorus, potassium, zinc, magnesium, manganese, 
vitamin B l, B9, C, D, E, K and retinol equivalent. Intakes of protein, 
vitamin A, B2 and B6 were identical between FFQl and FFQ2. Nutrients 
were normally distributed except for carbohydrate, calcium, iron, sodium, 
manganese, vitamin A, B l, B6, B9, B12, C and D. They were logged to the 
natural transformed. No significant differences were found between FFQl 
and FFQ2 (paired t-test p<0.05). The average p-value was 0.55. It ranged
1 0 7
from 0.16 for calcium to 0.99 for protein. The average Pearson correlation 
co-efficient was 0.520 for crude nutrient intake and 0.527 for energy- 
adjusted nutrients. It ranged from 0.065 for crude calcium intake to 0.948 
for crude vitamin D intake, and from 0.006 for vitamin C energy adjusted to 
0.926 for vitamin D energy adjusted intake (Table 16). The classification of 
the nutrient intake into thirds showed an average of ‘correctly classified’ at 
65% and into fifths an average of ‘correctly classified’ at over 31% (Table 
17& 18).
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Table 18 Classification of women into thirds of nutrient intake for the initial 
and repeat FFQ in long-term (LT) reproducibility study
LT Reproducibility
Nutrient Validation % (n) correctly classified
Energy 43 (6)
Protein 71 (10)
Fat 50(7)
Carbohydrate 29(4)
Fibre 57(8)
Calcium 43(6)
Iron 43(6)
Phosphorus 50(7)
Potassium 43(6)
Magnesium 36(5)
Vitamin B12 50(7)
Vitamin C 64(9)
Vitamin D 64(9)
Vitamin K 50(7)
4.8 Discussion
With respect to the present study, this developed FFQ is the first of its kind, 
which has been adapted specifically to the elderly population in Switzerland. 
The FFQ was developed following recommendations for determining the 
food list, the portion sizes and the frequency options, according to the studied 
population. When comparing the FFQ results with the WR results in the 
validation study, similar values were found for the nutrient intakes. This 
suggested a good consistency in estimating nutrients. Assessment of energy 
intake by the FFQ was well estimated, suggesting that the portion sizes of 
each food item in the FFQ and the 4d WR were quite accurate. This would 
have the effect of allowing subjects to be ranked according to energy intake 
by both methods. Using weighed records as the reference method, the 
study’s data suggests that the nutrient intake estimation by the FFQ was good 
for the majority of the macro and micronutrients assessed. The sample size 
used in this study’s validation work has enabled sufficient statistical power to
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examine any changes between 0.55SD to 0.58SD, for a range of macro and 
micronutrients at 80% power (P<0.05). The subject numbers studied (n=44) 
were similar to those used in previous validation work [205-207] and with 
the use of the WR technique, (which is considered the gold standard for 
dietary methodology studies), it was considered that adequate power was 
available to test for specific changes in nutrient intake between the two 
dietary methodologies. The subjects used for the validation study are also 
the subjects from whose dietary records the FFQ was developed. Given the 
specific age range (75-87 yrs) of the subjects, the decision was made to use 
the same subjects from the validation study for the development of the FFQ, 
the reason being that it is very difficult to recruit sufficient numbers of 
women at that age level. This could have induced a potential bias and led to 
better agreement between the methods, but it does not seem that this has 
adversely affected the results.
Furthermore, WRs are not free from measurement error. However, they are 
regarded as the most accurate quantitative measure of nutrient intake. It was 
assumed that Weighed Records represent a reliable reference measurement. 
Ideally, nutrient biomarkers should be used as a standard reference method. 
However, their use is limited because biomarkers do not exist for all the key 
nutrients and are also very expensive.
The validation correlations were very similar to other validation studies in 
the elderly [199], but also in studies undertaken in younger subjects [208- 
209]. However, a minority of nutrients are poorly assessed by this FFQ. The 
correlation co-efficients for vitamin D between the FFQ and 4d WR show no 
relationship. In the reproducibility studies, all paired t-tests were non­
significant. However, correlation co-efficients in the long-term
i n
reproducibility demonstrated no relationship between FFQl and FFQ2 for 
crude calcium, Vitamin A and B2 and energy-adjusted vitamin C. This 
illustrates the risk of measurement error in FFQs. The various sources of 
error are multiple. In WRs, subjects may consciously or subconsciously 
over- or under-estimate their food intake [187]. Also, in the study’s group of 
elderly women, minor memory or mental dysfunctions cannot be excluded. 
The mean energy intake to BMR ratio, (EI:BMR) ratio (El), from the FFQ was 
1.24 (SD +/- 0.33 MJ) [210]. This does indicate some under-reporting, 
although it is important to note that the average age of women in this cohort 
was 80.3 years and hence, it is possible that there may be some over-estimation 
regarding the BMR equation. It has been demonstrated that the elderly tend to 
underestimate their intakes when completing dietary recalls and dietary records 
[190]. Moreover, other studies have also found low EIiBMR values. 
Andersson et al found a mean EI/BMR of 1.25 (SD +/- 0.33 MJ) [211].
In FFQs, a food that is crucial for several subjects may not figure in the food 
list. There are many different factors that can induce measurement errors 
and it is difficult to determine those that are responsible. The correlation co­
efficients for non-adjusted nutrients were mostly lower than the correlation 
co-efficients after adjustment for energy. This demonstrates that the 
variability of the nutrient consumption is related to energy intake. The 
correlation co-efficient is higher for non-adjusted nutrients, compared to 
energy adjusted nutrients, when variability of the nutrient depends on 
systematic errors of over- or under-estimation [187]. For this reason, it is 
suggested that crude nutrient intake should be energy-adjusted.
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4.9 Conclusion
These results demonstrate that it is possible to develop FFQs for the elderly 
population and collect data in large-scale epidemiological studies, with good 
validity. This FFQ could now also be used for other dietary studies of the 
elderly in Switzerland (Appendix 7 and 10).
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5. ENERGY A N D  NUTRIENT INTAKE OF 
SW ISS W O M EN  AGED 75 TO 87 YEARS
5.1 Introduction
Major industrialised countries, such as Switzerland, are undergoing important 
demographic changes. Due to declining birth rates and an increase in 
longevity, the proportion of older to younger people is increasing. While the 
overall Swiss population is projected to grow only slightly between 1990 and 
2020, the percentage of the population older than 75 is expected to double 
during this same period [212]. Rapidly escalating healthcare costs are a major 
concern in Switzerland, and the majority of these costs are used for the 
treatment of chronic diseases associated with aging, such as cancer, 
cardiovascular disease, diabetes and osteoporosis. The incidenee of these 
disorders and their associated costs are expected to steadily increase, as the 
population ages. Together with regular exercise, optimal nutrition can slow 
many of the health changes attributed to aging. Inadequate nutrition during 
old age contributes to the progression of existing diseases, such as 
cardiovascular disease, diabetes or osteoporosis, but also increases the risk of 
numerous health problems such as infection or dehydration [213]. It is well 
established that food intake decreases with age due to malabsorption, 
sedentarity, decline of smell and taste, chewing difficulties, social isolation 
and financial problems [214].
Understanding the dietary habits of a population is imperative, in order to 
adapt appropriate messages regarding nutritional requirements and cultural 
habits. Furthermore, assessment of dietary intake in specific populations, is 
a critical component when determining the effect of nutritional factors on
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specific health issues [186]. For the assessment of average, long-term dietary 
intake in large numbers of individuals. Food Frequency Questionnaires (FFQ) 
have emerged as particularly useful tools, since they can provide an 
approximation of usual, long-term dietary intake (rather than short-term 
records), can be self-administered and are relatively inexpensive to use [187]. 
Aceurate assessment of the dietary pattern in the elderly, Swiss population 
has not been widely studied [215].
The present chapter examines the energy, macro-nutrient and micro-nutrient 
intakes of the elderly, Swiss population. The study’s objective was to 
examine the nutrient intake and dietary pattems in the cohort of 401 
ambulatory women, from the Lausanne area, as already described in Chapter 
3.
5.2 Methods
The cohort of 401 elderly, ambulatory women, discussed in detail in chapter 
3, took part in the EVANIBUS study.
Once the FFQ was validated and ready to be used (as detailed in Chapter 4), 
all subjects came to the hospital for their only appointment, during which 
several parameters were measured with the FFQ, including energy and 
nutrient intake.
Prior to their visit, each woman received the FFQ by post, completed it at 
home and brought it back to the hospital at the time of their appointment. A 
dietician discussed each FFQ with the respondent and helped to complete any 
missing answers with them, where necessary. The FFQs were coded to insure 
anonymous data. The results from the 401 analysed FFQs are presented here.
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5.3 Statistical analysis
All analyses were performed by using the SPSS statistical software package 
(version 12, Chicago). Normality was tested by Kolmogorov-Smirnov. All 
nutrients not normally distributed were logged to the natural transformed 
[200-202,216].
5.4 Results
First, the qualitative aspect of the diet was analysed. The recommended 
frequency of consumption of the different food groups was compared to the 
frequency of consumption of the food groups by the elderly women (table 19 
+ Figure 20). This showed a qualitatively, very balanced diet. Each food 
group was consumed at the recommended frequency.
Table 19 Comparison of the recommended frequency of 
consumption of the different food groups and the frequency of 
consumption of the food groups
Food Group | RDA Average daily frequency of consumption
Bread and cereals 3 3
Vegetables 2-3 2.1
Fruit 2-3 2
Meat, fish and eggs 1 1.2
Milk & dairy products 2-3 3.1
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FIG. 20 COMPARISON OF THE RECOMMENDED FREQUENCY OF CONSUM PTION  
OF THE DIFFERENT FOOD GROUPS ACCORDING TO THE SW ISS FOOD PYRAM ID  
AND THE FREQUENCY OF CONSUM PTION OF THE FOOD GROUPS (SHOW N IN
RED INSIDE THE PYRAM ID)
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
The quantitative aspect of the diet was then analysed. The results show that 
nutrient intake appears to be low, compared with standards (Table 20). 
Energy, fat, carbohydrate, calcium, magnesium, vitamin C, D and E were 
insufficient when compared to the Swiss RNl [217]. Protein, phosphorus, 
potassium, iron and vitamin B6 were within the recommendations. The 
mean daily energy intake was 1544 kcal (+ 447.7) and the mean daily 
protein intake was 65.2 g (+ 19.9). With regard to body weight, subjects 
consumed 1.03 g/kg per day. In 26.2% of subjects, the intake was below 
0.8g/kg per day and in 8.5%, below 0.6 g/kg per day. However, 29.9% of 
subjects were above 1.2 g/kg per day and 12% were above 1.5 g/kg per day. 
Concerning the mean daily energy intake, 49.9% of women were below 
1500 kcal.
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Table 20 Comparison of the 401 FFQs against the RNI 
(Recommended Nutritional Intake
Nutrients RNI Mean FFQ intake (SD) % of RNI
Energy (kcal) 2069 1544 (+447.7) 74.6
Protein (g) 62.7 65.2 (±19.9) 103.9
Fat (g) 69 63.9 (±21.3) 9Z6
Carbohydrate (g) >25&6 163.8 (±54.4) 63.3
Minerals
Calcium (mg) 1000 983.1 (±388.7) 98J
Phosphorus (mg) 700 1163.7 (±391.5) 166.2
Magnesium (mg) 300 287.7 (±93.1) 95.9
Potassium (mg) 2000 2761.4 (±874.6) 138.1
Iron (mg) 10 11.6 (±3.7) 116
Vitamins
Vitamin B6 (gg) 1.2 1.25 (+0.44) 104.2
Vitamin C (gg) 100 93.1 (±45.2) 93.1
Vitamin D (gg) 10 2.49 (±1.45) 24.9
Vitamin E (gg) 11 9.39 (±3.88) 85.4
Table 21 shows the percentage of subjects falling below the Swiss RNI 
[217]. More than 50% of subjects do not cover their nutritional needs in 
energy, protein, fat, carbohydrate, calcium, magnesium, vitamin B6, C, D 
and E.
Table 21 Percentage of elderly women with intakes falling
below the RNI
Nutrients %
Energy (kcal) 87.8
Protein (g) 50.9
Fat (g) 623
Carbohydrate (g) 93.8
Calcium (mg) 58.9
Phosphorus (mg) 9.2
Magnesium (mg) 59^
Potassium (mg) 18
Iron (mg) 392
Vitamin B6 (gg) 51.1
Vitamin C (gg) 64.3
Vitamin D (gg) 99.8
Vitamin E (gg) 70.6
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5.5 Discussion
The present study reports energy and nutrient intake data in the elderly, 
Swiss, female population. Its main aim was to assess the nutrient intake and 
dietary pattems of elderly, Swiss women. A comparison of their diet with 
the Swiss RNI (Recommended Nutritional Intake) was done.
It can be assumed that in this study, the subjects were probably in better 
physical and mental health than the general elderly Swiss population. 
Indeed, they were willing and capable of coming to the hospital by 
themselves. Subjects in poor health are often not willing to participate to 
studies [218]. It can be assumed that in studies with elderly people there is a 
selectivity in favour of subjects in better health. Since health status is related 
to dietary intake, these findings of energy and nutrient are probably very 
optimistic. Furthermore, the mean BMI value of 25.2 kg/m2 indicates a 
tendency to overweight and is clearly higher than the expected BMI, our 
subjects are clearly in better health than the general population.
The elderly population has specific nutritional needs. As one ages, many 
changes occur, such as body composition and physiology, and on top of 
these changes, there are many factors which influence the quality and 
quantity of food consumed by the elderly population: Social, lifestyle, 
economic and medical conditions. The elderly are recommended to 
consume nutrient-dense foods and avoid “empty” calorie foods.
With age, smell and taste also decrease, again resulting in a negative impact 
on the elderly diet. This may explain why too much salt tends to be used; in 
this respect, the use of spices and aromatic herbs might help to brighten up 
meal times.
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Results of this study show an insufficient intake of energy, fat, 
carbohydrates, calcium, magnesium, and vitamins C, D and E. These 
nutrients play a major role in order to achieve optimal health and a 
deficiency poses a risk factor for many diseases, such as cardio-vascular 
disease, cancer and osteoporosis.
Energv. fat, carbohvdrate. protein
The body’s needs in energy, fat and carbohydrate decreases in the elderly. 
Over time, muscle decreases by about 15% in the sedentary elderly and the 
% of body fat consequently increases. These changes lead to a decrease in 
energy needs by about 10% per decade.
However, as nutrient needs stay approximately the same, this highlights the 
complexity of the elderly nutritional requirements, i.e. whilst they may eat 
less, their diet should still be adequate in the same amount of nutrients. If it 
is not, they are at high risk of nutrient deficiencies, as discussed below.
The mean daily intake of 1544 kcal in this study is in the intake range 
reported in different European towns in the Euronut SENECA follow-up 
study (1310-2400 kcal) [214, 219]. However, it is higher than reported in 
several other studies with free-living elderly and could be due to the 
particularly healthy subjects taking part in this study [219-220]. Percentage 
of energy derived from protein was quite high: 17%. This has also been 
reported from other groups of elderly subjects [221]. 7% were above 1.5g of 
protein/kg a day and could therefore be at risk for negative effects such as 
increased urinary excretion of calcium which has been shown to increase 
with high animal source protein intakes, especially in an older age group 
[222].
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Calcium and vitamin D
Vitamin D intake results are very low. 99.8% of the studied population was 
below the RNI for vitamin D. Low intake levels of vitamin D have also been 
reported from other samples of elderly subjects [219-220]. The European 
dietary habits make the recommendations for vitamin D very difficult to 
reach. The main dietary sources of fatty fish and eggs are often not often 
consumed by the Swiss population where fish, in particular, is not a food 
consumed on a daily basis.
The benefit of sufficient calcium and vitamin D intake on bone health is well 
established and an oral vitamin D supplementation, between 700 to 800 lU/d, 
appears to reduce the risk of hip and non-vertebral fractures in the elderly 
population living at home, or in institutions [223]. Indeed, vitamin D is 
produced by the skin when exposed to direct sunshine and is also provided by 
the daily nutrient intake. These two sources may provide enough supply, but if 
one source is lacking, the other source can become insufficient; generally 
speaking, the elderly avoid direct sun exposure [224]. Several studies have 
dosed the serum 25(OH) D in independent subjects and found low levels in a 
large percentage of the population [225].
The calcium intake is nearly within the recommendations: 980 mg per day. 
This is relatively high for this elderly population and could be due to the fact 
the Swiss eat a lot of hard cheese. In the winter, several typical dishes are 
cooked with 200g of hard cheese per person. These are often consumed at least 
once a week, even in this elderly population.
In pre-menopausal women, the impact of calcium on bone mineral density is 
not always proved. Several studies on women under 40 did not show a 
relation between vertebral or femoral bone density and calcium intakes.
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However, more recent studies have shown a positive effect [28, 106]. In 
1995, Welten et a l undertook a meta analysis of around 20 published 
studies and concluded a positive effect of calcium intakes and bone mineral 
density in women aged between 25 to 40 years old [107].
The same effect has been shown in peri-menopausal women. A meta 
analysis of 6 studies on women over 50 during menopause, receiving a daily 
lOOOmg calcium supplement, decreased physiological osteopenia by 50% 
[226].
In old age, the decrease in intestinal calcium absorption is associated with a 
decreased dietary intake and a deficient vitamin D status, as well as a 
compensatory hyperparathyroidism [111], which leads to an increase in 
bone resorption [112]. However, a vitamin D supplementation is very 
efficient to correct deficiency in old people and this also has a beneficial 
effect on bone. Furthermore, the elderly have greater difficulty in producing 
vitamin D, and so there is an obvious increased reliance on dietary sources 
of vitamin D
Magnesium
The magnesium intake is nearly within the recommendations : 290 mg per day. 
This could be due to the fact the Swiss population eats bread daily and favors 
whole grain bread. This is an important source of magnesium.
The elderly Swiss population also eats a type of porridge called “bircher” in 
which they add whole grains like oats, dried fruit and nuts.
It has been shown that osteoporotic, post-menopausal women have lower 
plasmatic magnesium levels, than non-osteoporotic subjects [148]. The 
mechanisms for this remain unclear.
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Magnesium seems to directly stimulate osteoblastic proliferation, which 
would suggest that a deficiency could induce a decrease in bone formation 
[149]. A decrease may also be responsible for a modification in the skeletal 
resistance [150]. Subjects with a magnesium deficiency have also been 
shown to have lower levels of 1,25 (0H)2-vitamin D and PTH, both of 
which have a direct effect on bone formation.
Magnesium is therefore important to bone health as it is implicated in 
skeletal growth and in maintaining bone health during adulthood and old 
age. A deficiency in magnesium is considered as a risk factor for 
osteoporosis.
Vitamin C and E
The vitamin C intakes are nearly within the recommendations: 93 mg per day. 
Often, the elderly population decreases their intakes of fresh and uncooked 
fruit and vegetable due to chewing problems. However, in this particularly 
healthy group of elderly, the consumption of uncooked fruit and vegetables 
(particularly salad) was high and often daily.
The vitamin E levels were 15% below the RNI. Seed and nut oils are a good 
source; however this Swiss elderly population is often used to cooking with 
butter rather oil or margarine rich in vitamin E.
It is believed that oxidant damage to DNA, protein, and other 
macromolecules is responsible to a large extent for cardio-vascular disease 
and other age-related degenerative conditions, such as cataracts and 
cognitive dysfunction. Maintenance of tissue integrity is dependent on the 
balance between the production and neutralization of toxic oxidants. The 
possible protective effects of vitamins E and C and carotenoids, against the
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onset of chronie diseases, are currently under investigation. It is believed 
that these nutrients function as antioxidants and act as scavengers of free 
radicals, either independently, or as part of larger enzyme systems.
Basal Metabolic Rate
The Basal Metabolic Rate (BMR) is one of the major components of energy 
expenditure. The BMR of the elderly is approximately 9-12% lower than that 
of adults. This is mainly because of a decline in lean body mass. Reduced 
physical activity leads to accelerated loss of muscle [227]. The mean energy 
intake (El) to BMR ratio for the group was 1.24 (SD +/- 0.33 MJ). This does 
indicate some under-reporting in the group, although it is important to note 
that the average age of women in this cohort was 80.4 years and hence, the 
BMR equation may be somewhat over-estimated [210]. It has been 
demonstrated that the elderly tend to underestimate their intakes when 
completing dietary recalls and dietary records [190]. This low ratio could also 
be explained by the fact that there is a natural tendency to eat less with age. 
The ability to ingest sufficient energy declines and it could be that these 
women are just not eating enough, however the subjects from this study are of 
normal healthy weight which suggests that they are eating enough. Moreover, 
other studies have also found low EI/BMR. Andersson et al. also found a 
mean EI/BMR of 1.25 (SD +/- 0.33 MJ) [211]. They conclude that the women 
may have been more attentive about their food consumption and quantities 
during the recording period.
It has been suggested that an adequate micronutrient intake for the elderly, to 
achieve their minimal, daily energy levels, is 1500 keal [228]. The study 
indicates that nearly 50% of subjects were below this minimum level. The 
intake for several nutrients, essential to optimum bone health, was also
19/;
insufficient. Amongst others, 58.9% of subjeets are below the RNI for 
calcium and 99.8% of subjects are below the RNI for vitamin D intake. 
Findings for energy and nutrient intake in the present study are very similar to 
those of previous studies, as shown in Table 22 overleaf.
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The Swiss longitudinal SENECA study examined the nutritional and health 
status of 70 to 75-year old elderly women living at home, with particular 
emphasis on their food habits, amongst other factors. Low energy intake 
(<1200 kcal) was measured in 24% of women and mean daily calcium intake 
was 828 mg [215]. The European Nutrition and Health Report 2004 and 
Volkert et al also showed results very similar to the present study [213,229].
Upon examination of the characteristics of the women included in the study, 
a bias was concluded in the studied population, especially as the mean BMI 
is over 25, which appears quite high for women of 80.4 yrs. However, 4.1% 
of women had a BMI below 18.5 kg/m2. The risk of malnutrition in the 
elderly living at home is approximately 12% [230], and it was therefore 
deemed correct to assume that these female participants were probably in 
better health than their counterparts in the general population, and that they 
were particularly motivated by their health status. They were fit enough to 
travel to the hospital for the study consultation and to complete the FFQ by 
themselves at home. It is probable that the food quantities of the general, 
elderly population are even lower than the women who partieipated, and 
who have an interest in their health. Furthermore, the consumption of 
certain foods often decreases with age, because of dental reasons, other 
digestive problems and financial concerns.
5.6 Conclusion
In conclusion, it can be summarised that the nutrient intake in this cohort of 
independently-living, elderly, Swiss women was low, compared to standards. 
Vitamin D was found to be critically low compared to RNI and 50% of 
women were at risk of malnutrition, due to low-energy intake.
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6. LOW ESTIMATES OF DIETARY 
ACID LOAD ARE POSITIVELY 
ASSOCIATED WITH BONE 
ULTRASOUND IN WOMEN 
OLDER THAN 75 YEARS WITH 
A LIFETIME FRACTURE
6.1 Introduction
There is growing evidence to suggest that the Western diet is a risk factor 
for osteoporosis, as a result of excess acid supply, and that fruit and 
vegetable intake balances the excess acidity, mostly by providing 
potassium-rich, bicarbonate-rich foods [231-233]. Indeed, Western diets 
consumed by adults generate 50-100 mEq acid/d [234]. Therefore, healthy 
adults consuming such a diet are at risk of chronie, low grade metabolic 
acidosis, which worsens with age, due to a decline in kidney fimetion [117].
Maintenance of acid-base homeostasis is tightly regulated in the extra­
cellular fluid at pH 7.4 (± 0.05) [181]. Almost every biological process in 
the human body is dependent on the acid-base balance, including bone 
metabolism. Bone contributes to the acid-base homeostasis as it delivers 
cations such as magnesium, potassium, calcium and sodium, which can be 
associated with alkali salts such as citrate or carbonate. Over time, an over­
stimulation of this process will lead to the dissolution of the bone mineral 
content, and hence to a reduction in bone mass [117, 181]. Therefore, long­
term nutritional acid-load may be harmful to bone health.
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In vitro studies have shown that metabolic-acidosis induces a calcium efflux 
from bone [235]. In the animal and human model, an acid environment is 
associated with a negative calcium balance and increased bone loss [173- 
175]. Any reduction in extracellular pH enhances osteoclastic activity [236]. 
Even a small change in pH, near (pH 7.1) but not exactly to the 
physiological level (pH 7.4), stimulates osteoclasts [237]. Whilst this 
statement is theoretical, it may be concluded that on a long-term nutritional 
acidic load, pH is kept constant at the expense of bone, whieh delivers the 
buffering substances through bone resorption [167]. The acidification of 
bone is not only linked to osteoclastic stimulation; cultured osteoblasts also 
show reduced collagen synthesis and mineralisation in an acidic 
environment [171-172].
Nutrition has long been known to strongly influence acid-base balance in 
humans [163]. Intakes of potassium, magnesium, fruit and vegetables have 
been associated with a more alkaline environment in the human body, and 
have a beneficial effect on bone health [145]. In healthy male volunteers, an 
acid diet significantly increased urinary calcium excretion by 74% and 
urinary C-telopeptide excretion by 19%, when compared with an alkali diet 
[168].
In trans-sectional studies, the acid-base ratio has shown that there is a 
correlation between the nutritional acid load and bone health, measured by 
bone ultra-sound [238] or DXA [239]. However, data are still scarce.
The primary objective of this study was to investigate dietary and nutritional 
influences on bone health in the elderly, Swiss population and furthermore, 
to determine whether there is an association between low dietary acid load 
and bone ultrasound measurements (bone ultrasound attenuation). Indeed,
i n
this very elderly population has not yet been assessed in terms of evaluating 
dietary acid load and bone ultrasound measurements.
Specific objectives:
Is poor macro and micronutrient intake associated with lower 
calcaneal bone mass (as measured by ultrasound attenuation)?
Is a high estimate of dietary acidity associated with an increase in 
fracture risk?
Is poor dietary quality associated with lower bone health and higher 
fracture risk, between bone health indices measured by bone ultra­
sound and nutrient intake measured by the FFQ?
Hypothesis:
The hypotheses to be tested are that:
• poor macro and micronutrient intake is associated with lower 
calcaneal bone mass.
• a high estimate of dietary acidity is associated with an increase in 
fracture risk.
• poor dietary quality is associated with lower bone health and higher 
fracture risk between bone health indices measured by bone ultra­
sound and nutrient intake measured by the FFQ.
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6.2 Methods
The cohort of 401 elderly, ambulatory women has already been detailed in 
chapter 3 (age 80.4 y, BMI: 25.2 kg/m^). No significant effects of the acid 
load were observed in the whole group, which led to a separate examination 
of women with a fracture history. Therefore, two sub-groups were created; 
256 women with a fracture history (of which 15.2% were treated for 
osteoporosis including hormone replacement therapy) and 145 non-fractured 
women (of which 7.6% were treated). Indeed, previous fracture is an 
important risk factor for a second fracture, and represents one component of 
many independent, clinieal risk factors such as body weight, co-morbidities, 
genetic risks, physical weakness and nutrition. During their one and only 
visit to the hospital, participants were asked if they had ever had one or 
several fractures, in their life. As many women had difficulty recalling year, 
type and cause of fracture, all women reporting any lifetime fracture were 
included in the fracture history sub-group. All patients were also weighed 
and measured.
The Mini Nutritional Assessment (MNA), a non-invasive and validated 
questionnaire to evaluate nutritional status in elderly people, was completed 
by each woman [240]. The purpose of the MNA, comprising 18 questions, 
was to evaluate the nutritional status of each subject, with the score ranging 
from 0-30 (<17 indicates malnutrition, 17.5-23.5 risk of malnutrition and > 24 
well nourished). Quantitative bone ultrasounds were performed on each 
participant. The non-dominant foot was measured. The Lunar-Achilles bone 
ultrasound machine was used and one result was obtained (BUA-bone 
ultrasound attenuation, SOS-speed of sound, Sl-stiffness index). The 
machine was calibrated on a weekly basis with a physical phantom.
I l l
Prior to their visit, all women received by post the Food Frequency 
Questionnaire (FFQ), specifically designed for this study, and detailed in 
chapter 4 [241]. They completed it at home and returned it at the time of their 
appointment with a dietician, who then discussed it with the respondent and 
helped to complete any missing answers. The FFQ was designed to estimate 
the usual food intake over the previous year and all were coded to insure 
anonymous data.
During the past few decades, a number of researchers have used in vitro 
methods, which are inappropriate to specifically determine the acid or 
alkaline producing potential of the diet [176]. Frassetto and colleagues have 
estimated the net endogenous, non-carbonic acid production (NEAP) from 
the diets of normal adults. This is another method used to measure the acid- 
base ratio, which is based on the dietary protein to potassium ratio in normal 
diets [177]. Once again, this method has limitations when estimating the 
acid-base ratio of whole diets, because it does not take into account the 
absorption rates of these nutrients.
Estimated NEAP (mEq/d) = 
[54.5 X protein (g/d) / potassium (mEq/d)] -1 0 .2
Therefore, a more accurate in vitro measurement of the acid-base ratio has 
been determined using a calculation model, developed by Remer and Manz 
[178-179]. They have estimated the net acid load from average intestinal 
absorption rates of ingested protein and additional minerals, as well as an 
anthropometry-based estimate, for organic acid excretion.
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Estimated NEAP: PRAL (mEq/d) + OAest (mEq/d) [180]
Where PRAL denotes potential renal acid load and OAest denotes estimated 
urinary organic anions, the two components are calculated as follows:
PRAL (mEq/d) =
0.49 X protein (g/d) + 0.037 x phosphorus (mg/d) -  0.021 x potassium 
(mg/d) -  0.026 X magnesium (mg/d) -  0.013 x calcium (mg/d)
OAest (mEq/d) = individual body surface area [0.007184 -  height (cm) 
-  weight (kg) I X 41/1.73
The traditional, potential renal acid load (PRAL) index was calculated for 
each individual with the following nutrients using the formula:
PRAL (mEq/d) = (phosphorus mg/d x 0.037 + protein g/d x 0.49)- 
(potassium mg/d x 0.021+ magnesium mg/d x 0.0263 + calcium mg/d x
0.013) [179].
In accordance with the standardisation terminology agreement, as proposed 
by Frassetto and colleagues, the study refers to this calculation as ‘estimates 
of NEAP’ [ISO]. As with other research, it was decided to omit sodium and 
chloride [238], because the current study’s FFQ could not quantify the salt 
added to food. Additionally, although other authors of comparable studies 
did use the OA/body surface aspect of Remer’s method, it has also been 
omitted from this current study as the researchers were not confident of the 
validity of its use in very elderly individuals (mean age 80 years).
6.3 Statistics
All analyses were performed by using the SPSS statistical software package 
(version 14, Chicago).
Descriptive statistics (means, SD, and ranges) were determined for all 
variables. Data were checked for normality with the Kolmogorov Smirnov 
test. No variables were normally distributed; they were therefore logged to 
the natural transformed and parametric tests were then used.
Significant differences between both sub-groups were calculated with 
independent t-tests. NEAP values, calculated on absolute nutrient intakes, 
were divided into tertiles and the corresponding mean values of BUA were 
calculated. Differences between BUA among the NEAP tertiles were 
assessed by using the F Test for linearity and one-way ANOVA with post- 
hoc test (Tukey test).
Analysis of co-variance was used to assess differences after adjustment for 
important confounding factors (age, BMI and osteoporosis treatment). BUA 
values were divided into quartiles, and the mean values of MNA were 
calculated. Differences between MNA among the BUA quartiles were 
assessed by using the F Test for linearity and one-way ANOVA with post- 
hoc test (Tukey test). Stepwise multiple regression analysis was also used 
to determine whether the estimate of NEAP was an independent predictor of 
bone health.
6.4 Results 
Descriptive data
The age, anthropometric data, nutritional data and bone ultrasound 
measurements for all 401 subjects, together with the sub-groups of 256 
fractured women and 145 non-fractured women, are given (Table 23).
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Pearson correlations were then performed between the log transformed, energy 
adjusted nutrients and BUA. No significant effects of the acid load were 
observed in the whole group. Therefore, two sub-groups were created to see if 
there would be any difference between the fractured women and the non­
fractured women.
Table 24 Pearson correlation co-efficients
Pearson correlation co efficients
Ln-transformed variables, 
energy-adjusted for nutrients Ln BUA (n= 401) Ln BUA (n= 256) Ln BUA (n= 145)
NEAP 0.089 -0.142* 0.035
Age -0.159** -0.154* -0.105
BMI 0.313** 0.250** 0.354**
MNA 0.198** 0.0.146* 0.256**
Protein 0.015 0.032 -0.056
Fat -0.013 -0.060 0.057
Carbohydrate 0.005 0.020 -0.006
Calcium 0.088 0.151* -0.021
Phosphorus -0.018 0.026 -0.095
Sodium 0.058 0.005 0.120
Potassium 0.057 0.134* 0.024
Magnesium 0.052 0.095 -0.026
Vitamin C 0.036 0.053 0.008
Vitamin A 0.003 -0.027 0.033
Vitamin D -0.056 -0.050 0.077
Vitamin K 0.043 0.134* 0.024
Pearson correlations between anthropometric data and log transformed, 
energy adjusted nutrients and BUA (Broadband Ultrasound Attenuation)
The above results led to a separate examination of women with a fi'acture
history.
The mean values of the ültrasound parameters, BUA and SI (P<G.01)^w^ere 
significantly lower in the sub-group of fractured women, although they were 
only 8 months older (P<0.05) (see Table 24). The non-fractured sub-group 
showed no correlation between the bone-ultrasound measurements and
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nutrition. Consequently, all results presented hereafter are those of the sub­
group of 256 fractured women.
Correlations between estimates of NEAP, associate nutrients and BUA
Lower estimates of NEAP were significantly associated with higher BUA (r = 
-0.142, P<0.05). Higher estimates of calcium, potassium and vitamin K were 
significantly associated with higher BUA (r = 0.151, r = 0.134, r = 0.134; P< 
0.05). Differences remained significant after adjustment for age, BMI and 
osteoporosis treatment (table 24).
Tertile analysis between estimation o f NEAP and BUA
BUA decreased significantly between tertile 1 and tertile 3 for NEAP estimate 
(Table 25 and Fig. 21). A significant difference was found among the mean 
scores of BUA for the 3 groups, using the one-way ANOVA (P=0.03) with 
post-hoc test (Tukey test), as well as for the F test linearity (P= 0.03). 
Comparison of the means of BUA by tertiles of NEAP with post-hoc test 
(Tukey test) showed trends (T1-T2 P=0.052, T1-T3 P=0.070).
The difference in BUA between tertile 1 and 3 was 2.9 dB/MHz, which 
represents a 2.9% difference in bone ultrasound attenuation. Differences 
remained significant after adjusting for age, BMI and osteoporosis treatment 
(Table 25).
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Fig. 21
100.0-
^  98.0
94.0-
NEAP tertiles (mEq/d)
FIG. 21 (6) M EAN B U A  AND  NEAP IN 256 FRACTURED WOMEN
BUA, broadband ultrasound attenuation 
NEAP, net endogenous acid production 
T, tertile
The mean values o f  NEAP for T p , T2 and T3 were -1 5 .4 , -2.6 and 8.3 mEq, respectively
The mean BU A  values for T l, T2 and T3 o f  NEAP were 98.8, 95.6 and 95.9 dB/MHz, 
respectively.
*  A  significant difference was found among the mean scores o f  BUA for the 3 groups, using 
the one way ANOVA with post-hoc test (Tukey test) (p=0.03), as well as for the F test 
linearity (p= 0.03).
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Table 25 Characteristics of the studied population stratified by
tertiles
NEAP Unit Mean Std Deviation
T l Age y 80.06 3.23
N=63 BMI kg/m^ 25.1 0.5
NEAP mEq/d -15.35 6.72
Protein g 61.5 19.6
Calcium mg 1051.9 437.1
Potassium mg 3153.4 971.6
Magnesium mg 306.4 90.5
BUA db/MHz 98.8 9.5
MNA score 26.6 0.2
T2 Age y 80.97 2.7
N=64 BMI kg/m^ 24.4 0.5
NEAP mEq/d -2.59 0.31
Protein g 64.7 2.18
Calcium mg 1028.6 44.7
Potassium mg 2715.4 88.8
Magnesium mg 292.1 10.9
BUA db/MHz 95.6 1.1
MNA score 26.4 0.3
T3 Age y 80.9 0.3
N=60 BMI kg/m2 24.2 0.5
NEAP** mEq/d 8.3 0.7
Protein* g 71.9 2.2
Calcium mg 931.4 37.9
Potassium** mg 2535.1 85.9
Magnesium mg 282.2 10.4
BUA* db/MHz 95.9 0.8
MNA score 26.4 0.3
* p<0.05, ** p<0.01 Calculated with ANOVA with Scheffe’s test between T l
and T3 of NEAP
Estimation o f NEAP as an independent predictor o f  bone health
The stepwise regression analysis included BUA, NEAP, BMI, osteoporosis 
treatment, MNA and age. It explained 7.6% of the variation in BUA. BMI 
and osteoporosis treatment explained 6.3% and NEAP 1.3% (P<0.050).
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Age and MNA were excluded from the equation because they had no 
significant impact in the stepwise regression analysis.
NEAP was an independent predictor of BUA after BMI, with the following 
equation:
BUA= 86.7 + (0.2xBMI) -  (0.13xNEAP).
Age and MNA were excluded from this equation, as they had been excluded 
from the stepwise regression. When BMI was held constant (using the mean 
values for the group), the difference in BUA between + 1 SD of NEAP 
estimate was found to be 4.1%, with the lowest NEAP (most alkaline) being 
associated with the highest BUA. Absolute BUA values were 93.5 dB/MHz 
for the lowest and 89.7 dB/MHz for the highest NEAP estimate - a difference 
of 3.8 dB/MHz. Again, when BMI was held constant, the difference in BUA 
between the minimum and maximum intakes of NEAP estimate was found to 
be 10.6%. Absolute BUA values were 102.04 dB/MHz for the lowest and 
92.9 dB/MHz for the highest NEAP estimate - a difference of 9.14 dB/MHz.
Correlations between MNA and BUA
Although MNA was excluded from the stepwise regression analysis, a higher 
MNA score was significantly associated with higher BUA (r = 0.149, P< 
0.05).
Quartile analysis between MNA and BUA
BUA increased significantly between quartile 1 and quartile 4 for MNA 
(Q 1=23.5, Q2=26.5, Q3=28, Q4=30). The difference among the mean scores 
of BUA of the 4 groups was significant, according to the one-way ANOVA
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(P=0.004) with post-hoc test (Tukey test), as well as the F Test linearity (P= 
0.015). Comparison of the means of BUA by quartiles of MNA with post-hoc 
test (Tukey test) showed a significant difference between Q1-Q2 (P=0.004) 
and trends between Q1-Q3 (P=0.074), Q1-Q4 (P=0.076).
6.5 Discussion
This study suggests that lower estimates of NEAP are significantly associated 
with greater bone ultrasound measures, an effect that is independent of 
confounding factors such as BMI, age and osteoporosis treatment. Findings of 
this study also show that higher calcium, potassium and vitamin K intakes are 
associated with higher bone ultrasound measures. They are similar to previous 
studies and are in agreement with earlier human and animal studies, which 
showed the positive effect of dietary interventions, designed to alkalinise the 
blood and urine pH, on bone turnover [238-239]. However, caution is urged 
with the interpretation of these findings, given the study’s small size and that 
they are applicable to only a sub-group of the studied population.
Traditionally, the Net Endogenous non-carbonic Acid Production (NEAP) 
estimate, was based on the dietary protein to potassium ratio in normal diets 
[177]. This method has limitations when estimating the acid-base ratio of 
whole diets, because it does not take into account other nutrients and the 
absorption rate of those included in the formula. Remer and Manz developed 
a formula for calculating the acid or alkali load of each food item, or of a diet 
as a whole, namely the Potential Renal Acid Load (PRAL) [178-179]. It can 
be accurately calculated when the nutrient data for protein, P, Cl, K, Mg, 
calcium and Na is known and hence, PRAL estimates were used in this study. 
Calculations of Remer’s formula to body surface area were not performed. In
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accordance with the recent Consensus Acid-Base Conference paper, 
generalised terminology for NEAP estimates (29) were used. Protein 
contributes positively to BMD [242]; however, in excess, it also has an acidic 
effect on bone, which is thought to be undesirable and dependent upon the 
amino acid composition [243]. It is the metabolism of the sulphur amino 
acids, methionine and cysteine, which generate an acid load, resulting in a 
reduction in blood and urinary pH [117, 120].
Cross-sectional results of a population-based study showed that lower 
estimates of NEAP were correlated with greater spine and hip BMD, and 
greater forearm bone mass (measured by Axial dual energy x-ray 
absorptiometry-DXA) [239]. However, bone ultrasound also predicts fracture 
risk (SEMOF) and is easier and cheaper for large cohort studies [244]. For 
this reason, QUS was chosen for the current study. Parameters assessed by 
QUS Achilles (Lunar), which uses water as a coupling agent, include 
Broadband Ultrasound Attenuation (BUA), Speed of Sound (SOS), and the 
combined indices Stiffness Index (SI).
The 2.9 dB/MHz difference in BUA between NEAP tertile 1 and 3 represents 
approximately 30% of 1 SD (-1 SD doubles the fracture risk); it is clinically 
relevant as it is higher than the short-term reproducibility, which is 2.2 
dB/MHz [245]. It is also clinically meaningful, as BUA has been shown to be 
predictive of fracture and to be the preferential QUS parameter when assessing 
nutritional status [246]. There is no difference in fracture prediction compared 
to SOS or SI, which justifies their exclusion from the present data [247].
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The large EPIC-Norfolk cross-sectional study investigated the relation 
between PRAL and calcaneal Broadband Ultrasound Attenuation (BUA), in a 
younger population (mean age 62.9 y). It found ~ 2% difference in BUA 
between the highest and lowest quintiles of PRAL, close to the 2.9% of this 
study’s findings. The EPIC-Norfolk study also concluded that PRAL was 
inversely associated with bone ultrasound measures in women [238].
Elderly men are also at risk for osteoporosis-related fracture. However, there 
is no available data on elderly, Swiss men and the role of acid-load on bone 
health in the present study was therefore only able to look at Swiss women. 
Far less is known concerning the effect of dietary acid on bone in men. 
However, Tucker et al. (41) showed in a cohort from the Framingham Heart 
study that greater intakes of K, Mg and fruit and vegetable were associated 
with higher BMD/lower bone loss in men. Data from the UK EPIC-Norfolk 
study [238], found an association between higher dietary acid load and poorer 
bone ultrasound measures in women, but not in men. Therefore, as current 
literature is not conclusive so far on this point, the current study furthers 
knowledge in this area by looking at a much older group which, in terms of 
osteoporosis risk, is a very pertinent population to research. The risk of 
chronic, low-grade, metabolic acidosis worsens with age due to a decline in 
kidney function. This may be considered a confounding risk factor, but the 
study design did not include the assessment of Glomerular Filtration Rate 
(GFR) and there was no large age difference in the studied group (+ 3 y) 
[117].
Although nutrition plays an important role in the maintenance of bone health, 
regardless of fi'acture status, no association was found in non-fractured
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women. This lack of association is intriguing. Possible reasons may be a 
greater susceptibility of fractured women to the detrimental effect of dietary 
acidity. This has already been suspected in a previous study on 7788 elderly 
women where low nutritional intake was associated with higher fracture 
incidence, in the women with a high inactivity score and high fracture 
incidence [248]. The effect of the association between NEAP and BUA was 
relatively small, compared to the effect of age and BMI. However, nutritional 
acid load is an additional risk factor, which may be relevant in patients already 
known to be at high fracture risk.
The MNA also appears to be a useful tool for the evaluation of osteoporotic 
patients. It assesses the subject’s nutritional status and is positively correlated 
to BUA. In this study, BUA results were found to be significantly lower when 
the MNA score was below 24 (risk of malnutrition): Indeed, a trend for a 
correlation between the MNA and BUA has already been seen in a previous 
study [249]. Another study showed that 50% of elderly, independent women, 
who displayed an MNA score <27, had a tripled risk of having osteoporosis 
[250] .
As this study has been limited by its cross-sectional study design, only 
associations - and not causal relations -  may be stated; consequently, it has 
not been possible to draw strong conclusions regarding the influence of 
nutrition on bone health. Several of the NEAP nutrients have additional 
effects, apart from the acid-base balance on bone health and hence, may 
confound the size of the effect under observation. A good example of this is 
potassium, which not only influences the acid-base balance and acts as a
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surrogate measure of bicarbonate, but also has an effect on the processes that 
maintain calcium homeostasis, such as urinary calcium excretion [251] .
The sub-group analysis of patients, with and without fracture history, was not 
an apriori hypothesis, but a finding of the current explorations and naturally, 
this creates limitations. Although the study’s FFQ was validated, it is known 
that errors are associated with FFQs, such as measurement errors, as well as 
subjects’ motivation and memory [186]. However, the subjects in this study 
were probably in better health than the general population, as they were able to 
travel alone to the hospital and were particularly motivated by the status of 
their health [252]. In the Swiss longitudinal SENECA study, the nutritional and 
health status of the 70 to 75-year old elderly living at home had very similar 
intakes to the studied population [215]. Furthermore, the European Nutrition and 
Health Report 2004 [229] and Volkert et al. also showed results very similar to 
the subjects of this study [213]. The intakes of dietary acidity estimates as 
shown by Gannon et al [253] are certainly lower, although extensive under­
reporting in the NDNS datasets that the Gannon paper was addressing, has 
been reported. Furthermore, this FFQ slightly overestimated intakes and in 
addition to this, the participants may have higher intakes, due to the fact that 
they are independent, health conscious and in better health and cognitive 
function overall, than more vulnerable, elderly adults.
For future studies, a FFQ which evaluates Na and Cl added to food would be 
of interest, as they both have a substantial effect on bone health. It was also 
not possible to measure NEAP estimates from 24-h urine collections, which 
would have been an additional parameter.
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6.6 Conclusion
In conclusion, the findings of the present study suggest that lower estimates of 
NEAP (i.e. more alkaline diets) are significantly associated with higher indices 
of BUA, measured by bone ultrasound, in a sub-group of fractured women, of 
the very elderly population (mean age 80.6 y). Caution must be exercised 
when interpreting these findings, due to its small size and analysis of the sub­
group only; they are also independent of important, confounding factors such 
as BMI and age. The research data suggests that measures of NEAP may be 
an additional risk factor, which is particularly relevant to frail patients with a 
history of fracture and for this reason, are at high fracture risk.
1 4 9
7.EMINOS-2
Eau MINérale et os -2
7.1 Introduction
The positive association between low estimates of dietary acid load and bone 
ultrasound shown in our EVANIBUS study, in women greater than 75 years of 
age with a lifetime fracture, encouraged us to investigate the effect of alkaline 
load in a younger population. It was decided to assess the effect of drinking 
mineral water on pre-menopausal women, as the consumption of mineral 
water may be an easy and cheap way of positively influencing the acid-base 
balance.
The origins of mineral water can be traced back to early civilisations. The 
Romans searched for drinking water sources and developed them whilst 
establishing their empire [157]. In recent years, the consumption of mineral 
waters and bottled waters has increased [155]. There are different types of 
bottled water [254]: Spring water, purified water, sparkling bottled water, 
artesian water and well water.
Natural mineral water distinguishes itself from other bottled waters by its 
underground origin, its stable composition of minerals, and its original purity 
[157]. To avoid any alteration, natural mineral water must be bottled at source 
and can only undergo a strictly limited number of expressly authorised 
treatments. They now have a prominent place in the diet of industrialised 
countries’ [156]. For this reason, their impact on health needs to be assessed 
[155]. Very large variations exist in the composition of different mineral
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waters [254] and may therefore, have potentially beneficial, or harmful, effects 
on health, including bone health. Several mineral waters have a beneficial 
effect on bone metabolism which, so far, has been mainly attributed to their 
calcium content [160, 255-259]. Calcium-rich mineral waters have been 
shown to be an alternative to dairy products, as the calcium-bioavailability is 
similar, or even possibly better [260]. They have also been shown to decrease 
bone resorption [160]. Bicarbonate also seems to play an important role [161, 
168]. High content of bicarbonate may decrease bone resorption and increase 
bone mineral density, due to the alkalinity of this water.
Nutritional acid load contributes to age related bone loss [261]. To keep pH 
constant, the organism uses buffer systems such as bone, expiration of CO2  
and renal excretion of acids [181]. The endogenous production of acid, 
consequent to a normal Western diet, is approximately ImEq/kg body weight, 
per day [262] and to buffer this quantity, 2mEq of calcium is necessary [262]. 
The more acid precursors a diet contains, the greater the need for buffering 
[263] and the enhancement of bone resorption. In addition, with advanced 
age, the ability of the kidney to excrete acids declines [117].
In vitro, an efflux of calcium from bone tissue is already noted after three 
hours’ incubation in an acidic medium [264]. Indeed, bone has been shown to 
contribute to the maintenance of the extra-cellular fluid pH [237] and 
therefore, a low acid diet may contribute to the maintenance of bone mineral 
density [143]. In healthy subjects, supplements of potassium bicarbonate, 
potassium citrate and even mineral water, rich in bicarbonates, decreased the 
calciuria and bone resorption markers [123, 159, 166, 265].
1 5 1
Aims and objectives
1) To investigate whether a high bicarbonate and calcium intake from 
mineral water, decreases bone resorption more than calcium alone, in 
healthy subjects on a balanced diet, adapted to their energetic needs.
2) To investigate whether nutritional bicarbonate lowers bone resorption in 
the presence of calcium sufficiency.
7.2 Subjects and methods
For this open, randomised, controlled study, thirty female dieticians or student 
dieticians were recruited. The inclusion criteria were good health, 18-45 years 
and BMI at 18.5-25 kg/m^. The exclusion criteria were; medication interfering 
with calcium metabolism (diuretics, corticoids), pregnancy, and inclusion in 
other protocols. Participants were declared healthy after completion of a 
medical questionnaire, of whom twenty-three were on the contraceptive pill. 
The anthropometric data of the thirty subjects is shown in table 26.
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Table 26 Anthropometric data of the 30 subjects at baseline
(mean iiSD )
All subjects 
n = 30
Subjects on 
Water A 
n = 15
Subjects on Water B 
n=15
Weight (kg) 58.7±5.7 58.1+5.6 59.4+5.9
Height (m) 1.68±0.05 1.68±0.05 1.67+0.05
BMI (kg/m^) 20.9+2.0 2 0 .6 + 1 . 8 21.3+2.3
Age (years) 26.3± 7.3 26.3±7.6 26.3+7.3
No significant differences between the groups
The subjects were randomised into 2 groups using the method of randomly 
permuted blocks and assigned to mineral water A or B (Table 27 shows 
their composition). 4 of the 7 subjects not taking a contraceptive pill were 
randomly attributed to Water A and 3 to Water B.
Table 27 Composition of the 2 mineral waters
Water A Water B
mg/1 *) mmol/1 **) mEq/1
***^
mg/1 *) mmol/1 **) mEq/1
***^
Bicarbonate 291 4.8 4.8 2172 35.6 35.6
Calcium 520 13 26 548 13.7 27.4
Magnesium 35 1.4 2.9 65 2.7 5.4
Sodium 5.5 0 . 2 0 . 2 67 2.91 2.91
Chloride 5.6 0 . 2 0 . 2 1 0 . 6 0.3 0.3
Fluoride 0 . 2 0 . 0 1 1 0 . 0 1 1 0 . 1 0.005 0.005
Sulfate 1160 1 2 . 1 24.2 9 0.09 0.18
Potassium 1.55 0.04 0.04 6.5 0 . 2 0 . 2
PRAL*) +9.2 - 1 1 . 2
Manufacturers always ind 
Results of this trial are indie 
mEq/1 allow to asse 
*) PRAL 
(Remer et al. 1995,
licate the composition of mineral waters in mg/1, 
ated in mmol/1 for comparison with the literature, 
ss the acid, respectively the alkaline load, 
according to Remer and Manz 
Remer T, personal communication, 2007)
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Each subject was required to drink 1.5 litres per day of one of the two 
mineral waters, over a period of 28 days. One of the mineral waters is very 
rich in calcium (Water A, Adelbodner®, Switzerland) and the other is 
equally rich in calcium, but also rich in bicarbonate (Water B, 
Kryniczanka®, Poland). In addition, water A was also rich in sulphate, 
which increases the acid load. For the assessment of the acid or alkaline 
load of food, a calculation model has been developed by Remer and Manz 
[179] - the Potential Renal Acid Load (PRAL). PRAL can be accurately 
calculated when the nutrient data for protein, P, Cl, K, Mg, Ca and Na is 
known. Phosphate content of mineral water is negligible and for this 
reason, was not indicated. On request, both manufacturers confirmed that 
the phosphate content of their waters is non-significant and therefore, 
phosphate was not included in the PRAL algorithm. PRAL takes into 
account the average intestinal absorption rate of the respective components. 
It’s algorithm is :
(0.00049 X protein [mg]) + (0.027 x Cl [mg]) + (0.037 x P[mg]) -
(0.021 X K[mg]) -  (0.026 x Mg[mg]) -  (0.0413 x Na[mg]) -
(0.013 X Ca[mg]) [179].
This algorithm also takes into account methionine and cysteine, as 
nutritional sources of SO4 , derived from protein. However in mineral 
waters, SO4  is in solution. As result of this, a correction of the formula is 
justified by using the molecular weight of SO4  instead of the two amino 
acids which is 96, and an absorption rate of 70%, resulting in a conversion
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factor of 0.0146 instead of 0.00049 (Remer T, personal communication, 
2007). Therefore, the PRAL is;
+ 9.2 mEq/1 for water A (acid), and
-11.2 mEq/1 for water B (alkaline).
The subjects were informed of the aims of the study and gave written 
consent for their participation.
The study’s protocol was accepted by the Ethic Committee of the Faculty of 
Medicine at the University of Lausanne, Switzerland (Appendix 9). The 
study was conducted at the University Hospital.
Prior to the first of four visits to the hospital, the subjects were given full 
explanations by phone regarding the study and were questioned on their 
health status, to identify inclusion and exclusion criteria. Of the thirty-five 
volunteers who applied, thirty were eligible for inclusion. Five were not 
included as they lived too far away to be on time for the early morning 
appointments. At their initial visit, each subject received their bottles of 
mineral water and met with a qualified dietician, who explained the 
imperatives of the study, i.e. mainly the dietary recommendations, where 
each participant was given the same weighed and balanced diet plan for 28 
days. The diet plan followed the recommendations of the daily 
consumption frequencies as follows: 5 portions of fruit and vegetables, 3 
portions of starch, 3 portions of dairy products and 1 portion of meat, fish or 
egg. The diet plan included 1875 kcal, 237g of carbohydrate, 67g of lipids, 
75g of protein and 965mg of calcium (Appendix 4). Subjects were allowed 
to eat more or less starch, depending on their appetite and physical activity.
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although all the other food groups had to be consumed in the established 
quantities. All participants were required to drink 1.5 litres per day of the 
assigned mineral water. They were advised not to drink more than one cup 
of coffee or tea a day, not to drink alcohol and to drink a little tap water if 
they were really too thirsty. A glass of fruit juice had to be considered as a 
portion of fruit, and a glass of milk as a portion of dairy product. Subjects 
were asked to avoid salty, processed food and to salt their food moderately.
The following three visits occurred in the early morning of the first day, at 
two and four week intervals of the study. They enabled reception of the 24 
hour urine, collection of the fasting morning urine and blood sampling.
Blood tests
The following analyses were undertaken at baseline and at two and four 
weeks: Sodium, potassium, ionised and total calcium, phosphorus, alkaline 
phosphatase, albumin, creatinine, 25-OH vitamin D (DiaSorin, Stillwater, 
Minnesota, 55082-0285 USA, (RIA+extraction), intra- and interassay co­
efficients 8.6-12.5% and 6.1-13.2%, detection limit 2 pg/1), blood and 
urinary C-telopeptides (CTX), PTH (Intact PTH, Nichols Institute, San 
Clemente, CA 92673, USA, (CIA), intra- and interassay co-efficients 5.7- 
6.2% and 13-9.1%  detection limit 2 ng/1), glucose (baseline only) and blood 
cell count (baseline only). The electrolytes, albumin and alkaline 
phosphatase were analysed at the Routine Laboratory of the hospital, using 
standard methods. CTX (C-terminal fragment of the type I collagen) were 
assayed with the Beta-Cross Laps Elecsys, Roche Diagnostics GmbH, D- 
68293 Mannheim, (ECLIA), intra- and interassay co-efficients 1.6-4.7% and
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3.9-4.3%, detection limit 0.010 pg/1) at the Endocrinology Laboratory of the 
hospital. All the samples were hermetically closed at reception and 
transported to the Laboratory in less than 15 minutes. The measurement of 
ionised calcium was introduced during the trial and for this reason, it was 
performed only in five subjects on water A and seven subjects on water B. 
A multiple specific electrode automate was used (ABL 800, Radiometer, 
Copenhagen, RSCH).
Urinary tests
Calcium, sodium, potassium, creatinine, bicarbonate and pH were measured 
in the 24 hour urine and in the 2 hour fasting, morning urine (second 
miction). In addition, CTX were measured (Nordic Bioscience Diagnostics 
A/S, Herlev-Hovedgade 207, 2730 Herlev, Danemark, (ELISA), intra- and 
interassay co-efficients 4.7-9.4% and 6.6-16.3%, detection limit 0.050 
mg/1). Urine gas analysis was done with a gasometer (Bayer Diagnostics 
248) at the Paediatric Research Laboratory.
7.3 Statistical analysis
The results were analysed using Excel® functions, StatistiX 8  (Analytical 
Software, Tallahassee, FL, USA) and SPSS version 14.0 (SPSS Inc., 
Chicago, IL, USA). Differences were considered significant at p<0.05. 
Descriptive statistics were undertaken for all anthropometric parameters and 
analytical variables. For each variable, groups’ homogeneity was checked 
at baseline by Student t-tests. Groups were compared using paired changes 
from baseline by classical t-tests (Mean and SD), robust ones (Median and 
robust SD), as well as by Wilcoxon rank-sum tests.
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As results from these three tests are comparable, it was decided to present 
only the classical t-tests (Mean and SD).
7.4 Results
The two groups were comparable in age (group A: 26.3 yrs ±7.6; group B: 
26.3 yrs ±7.3) and BMI (group A: 20.6 ±1.8 kg/m2; group B: 21.3 ±2.3 
kg/m2). The blood formula and glycaemia were all in the reference limits. 
There were no significant differences among the two groups in any of the 
laboratory values, as well as in age, height, weight and BMI.
Being dieticians, the participants showed excellent compliance and perfect 
understanding of the diet plan. All thirty volunteers completed the study.
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Laboratory tests
Table 28 shows the analysed parameters in absolute values
Table 28 Biochemical results (mean + SD) of subjects under water A and
B
Units 1 Baseline value 2 weeks 4 weeks(n=15) (n=15) (n=15)
SERUM
PTH Water A ng/1 28.6 (±11.6) 27 (±9.4) 29.1 (± 15.9)
Water B 33.3 (±11) 26.1 (±10) ** 27.73 (±8.1)**
C-Telopeptides Water A 0.380 (±0.115) " 0.385 (±0.137) 0.389 (±0.110)
Water B gg/1 0.479 (±0.261) 0.413 (±0.198) 0.401 (±0.234)*
24 HOUR![JRINARY EXCRETION
pH Water A 6.33 (±0.46) 5.85 (±0.34)* 6.04 (± 0.35)
Water B 6.02 (± 0.50) 6.69 (±0.29)** 6.61 (±0.43)**
Bicarbonate Water A mmol 4.88 (± 5.52) 1.28 (±0.72)* 2.07 (± 1.92)
Water B 2.71 (±2.36) 12.99 (±7.84)** 13.77 (±6.67)**
Ca Water A mmol 4.65 (± 1.80) 5.64 (±1.48)* 5.51 (±1.16)*
Water B 3.79 (±1.90) 4.53 (±1.41)* 4.48 (±1.58)*
Na Water A mmol 123 (±35) 110 (±30) 119 (±41)
Water B 120 (±25) 143 (±57) 146 (+47)
K Water A mmol 69.4 (±26) 67.4 (± 8.6) 73.4 (± 18.5)
Water B 60.1 (±18.1) 70.5 (±20.1)* 78.7 (±21.3)**
Creatinine Water A pmol 9779 (±2362) 9975 (± 1639) 10515 (±1635)
Water B 9619 (±1781) 10143 (± 1415) 10542 (± 1823)
Water A C-Telopei  ^tides mg 2.8 (±1.02) 2.8 (± 1.42) 2.73 (±0.71)
Water B C-Telopeptides mg 3.13 (±2.04) 3.23 (± 1.41) 3.12 (±1.46)
2 HOUR FASTING URINE CORRECTED OVER CREATININE
pH Water A 5.70 (±0.52) 5.55 (0.36) 5.50 (±0.47)
Water B 5.62 (±0.5) 5.95 (±0.7) 6.27 (±0.6) **
Bicarbonate/Creat Water A mmol/mmol 0.14 (±0.20) 0.08 (± 0.06) 0.08 (± 0.09)
Water B 0.11 (±0.13) 0.32 (±0.45) 0.75 (± 1.09)*
Calcium/ Creat. Water A mmol/mmol 0.25 (±0.15) 0.29 (±0.16) 0.22 (±0.13)
Water B 0.21 (±0.13) 0.2 (±0.11) 0.17 (±0.09)
CTX/Creat.
A
Water mg/mmol 0.066 (± 0.040) 0.06 (±0.041) 0.048 (± 0.026) * *
Water B I 0.086 (± 0.066) 0.06 (± 0.039) 0.079 (± 0.098)
The four figures present the changes between baseline in the urine and serum 
parameters, at two and four weeks respectively, except for pH, which was expressed 
in absolute values.
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Blood tests
The following parameters remained stable during the four weeks of the 
trial and showed no significant differences between the two groups: 
Phosphorus, potassium, sodium, calcium, ionised calcium, alkaline 
phosphatase, albumine, creatinine and 25-OH vitamin D.
In group B, mean serum CTX changes between baseline to week four 
were significant (Fig. 22), as well as mean PTH changes (Fig. 23), while 
CTX and PTH stayed stable in group A. At week four, the changes in 
serum CTX and PTH were significantly different between the two 
groups.
Urinary tests 
24 hour urine
The urinary volume increased regularly in both groups between baseline 
and week four, with no significant difference between the two groups.
pH increased in group B between baseline and weeks two and four and 
was considerably different between both groups at four weeks (Fig. 24).
Mean changes in urinary bicarbonate excretion between baseline and 
weeks two and four were significant in group B and also significant 
between both groups at week four (Fig. 25).
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Creatinine and sodium excretion stayed stable and showed no significant 
differences between the two groups. Calcium excretion increased 
considerably between baseline and week four in both groups (by 34.5 
mg, SD 25.7 in group A p=0.020, and by 27.7 mg, SD 12.8 in group B 
p=0.019), with no significant difference between the groups. When 
expressed in percent of the absorbed calcium (calculated according to 
reference 266), the urinary calcium excretion was 62% on Water A and 
50% on Water B. Urinary CTX decreased slightly, but not extensively, 
in both groups and no significant differences were observed between the 
two groups. Potassium excretion was significantly different between 
both groups at week four (p=0.033). It remained stable in group A, but 
increased considerably in group B between baseline and week four (p= 
0.0015).
Fasting morning urine
Expressed as ratio with creatinine, calcium, sodium, and CTX stayed 
stable and showed no significant differences between the two groups. 
Bicarbonate increased in group B throughout the 4 weeks and was 
noticeably higher than in group A (p=0.014). pH increased in group B 
between baseline and week four (p=0.0006) and was significantly 
different between both groups at four weeks (p=0.0001). Potassium 
showed an increase in group B at week two (p=0.014) and week four 
(p=0.013).
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7.5 Discussion
A four week dietetic intervention, with 1.5 daily litres of calcium-rich 
mineral waters, showed that additional bicarbonate enhances inhibition of 
bone resorption. The effect of calcium rich mineral water on bone 
resorption has already been shown, but only in postmenopausal, calcium- 
deficient women [158, 160]. This study was performed in calcium- and 
oestrogen- sufficient women.
Since all subjects followed the same diet plan, it can be assumed that all 
differences observed were not influenced by changes in nutrition, but by 
the mineral waters alone.
Calcium
The increase in urinary calcium excretion by approximately 30mg/24 
hours is in line with the increased calcium intake of 800mg/d, from the 
mineral water. This is compatible with a fractional absorption rate of 
about 20% at the given intake of calcium. When expressed in percent of 
the absorbed calcium [266], the urinary calcium excretion was 
significantly lower (p<0.001) in Group B, perhaps showing an indirect 
sign of decreased bone resorption. Both waters had very low and similar 
concentrations of fluoride and chloride and, as previously discussed, 
phosphates content was negligible. It may therefore be concluded that 
none of these ions had an influence on the results of this study.
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Bicarbonate
Bicarbonate and urine pH increased significantly in Group B, showing 
the expected impact of Water B on the acid-base metabolism. The 
precision of the measurement of bicarbonate can be questioned, as the 
urine must be collected immediately after excretion and transported in an 
airless container. However, the results are concomitant with the change 
in bicarbonate intake, as already observed in a previous trial [159].
Potassium
The increase of potassium excretion on Water B cannot be explained 
either by the K contents of the waters which were low and similar, or by 
the food intake, which was controlled. It can, however, be explained by 
the enhanced delivery of bicarbonate to the renal tubules, which increases 
K excretion, the physiological rationale being the possibility to eliminate 
more K [267] .
Sulphate
In general, calcium and sulphate content in mineral water are positively 
correlated [268]. One can argue that the sulphate content of the two 
waters may play a role, since it was high in Water A. In Water B, 
however, calcium is associated with bicarbonate, but not with sulphate. 
In animals, sulphate supplementation increases calcium excretion [265, 
269-270], but studies in humans show contradictory results: Sulphates 
either have no effect [271] or increase calciuria due to their acidogenic 
action [272]. Indeed, acid load increases urine calcium excretion [272].
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The acid load produced by the sulphate is included in the PRAL formula, 
which shows the total acid load. When applied to the two mineral 
waters, it was estimated + 9.2 mEq/1 for water A (acid) and -  11.2 mEq/1 
for water B (alkaline). Therefore, the observed effects were enhanced by 
the acidity of water A and the alkalinity of water B and were not 
exclusively due to the difference in bicarbonate content.
PTH
Serum PTH decreased on water B, but not on water A. This was 
surprising because total calcium, as well as ionised calcium, remained 
stable. The same phenomenon was observed in a previous human study 
[161]. In dogs [273], metabolic alkalosis also decreased PTH secretion 
without any change in blood calcium, supposedly by modifying the 
calcium-sensors on the parathyroid glands. In the current study, the 
calcium-rich water A did not lower the PTH level, perhaps because the 
nutritional calcium intake was already relatively high at baseline. This 
does not exclude a short-term effect [158] which would not influence the 
blood parameters of the next morning. The inhibition of PTH observed 
in this study is therefore understood to be an effect of the alkali load, 
with respect to the trend of rising pH on parathyroid cells. This could 
also explain why bone resorption decreased.
Whatever underlying reasons may explain the difference in bone 
resorption; alkalinity versus acidity, or high bicarbonate versus low 
bicarbonate, with a direct effect on bone or mediated through PTH, 
observed results show that the composition of the mineral water is the
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determining factor. Other studies have also shown a decrease in bone 
resorption through nutritional alkaline load, either by potassium- 
bicarbonate [123], or an alkali diet with bicarbonate-rich mineral water 
[168] or potassium citrate [165]: The latter even increased bone mineral 
density.
This study may therefore conclude that, even under a free diet and high 
calcium intake, alkaline bicarbonate-rich mineral water inhibits bone 
resorption.
Limitations
The following limitations, however, are applicable to this study. The 
relatively, free diet implied that the changes in urinary excretions showed 
some differences between individuals, and that only the major changes 
became statistically significant. The number of subjects is low and the 
study may have consequently lacked power to detect more effects. 
Although participants were also dieticians and were fully qualified to 
follow the diet plans, mistakes cannot be completely excluded. The 
serum and urine samples were taken to the laboratories in approximately 
15 minutes, which could have influenced the pH and bicarbonate data; 
the differences between the two groups were consistent, however.
Future research (personal unpublished data)
As demonstrated in the EMINOS-2 study, in calcium sufficiency, an 
acid, calcium-rich water had no effect on bone resorption, while an
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alkaline, bicarbonate-rich water led to a significant decrease of PTH and 
of serum CTX in young, calcium sufficient women [274].
A second study, EMINOS-3 was therefore planned to investigate 
whether a sodium-bicarbonated alkaline mineral water, relatively low in 
calcium, decreases bone resorption, compared to a water low in 
bicarbonate but comparable in its calcium content, in healthy subjects on 
a balanced diet.
In a double crossover design, twenty-two female dieticians (aged 30.1 +/- 
5.5, BMI 21.5 +/- 2.3) were randomly assigned to a sequence of drinking 
two mineral waters with an equal calcium content, i.e., a low- 
bicarbonated mineral water (Water C) and a high-sodium-bicarbonated 
water (Water D). The sequence was as follows:
Group A: Two weeks on Water C, two weeks wash-out, and two weeks 
on Water D for half the group (n=l 1); and
Group B: Two weeks on Water D, two weeks wash-out, and two weeks 
on Water C (n=ll).
Measurements of blood and urine electrolytes were performed at 
baseline, after two, four and six weeks, and after 12 hours’ fasting. In 
addition, urinary pH and bicarbonate, serum PTH and serum C- 
telopeptides (CTX) were measured at the same time. There were no 
significant differences between the two groups for all the variables at 
baseline, except for height (p=0.02).
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In both groups, the values of the 2h fasting urine and of the 24h urinary 
excretion of bicarbonate, sodium and pH were significantly higher 
(p<0.05) after consumption of Water D, compared to the values after 
consumption of Water C. CTX/Cr and serum crosslaps stayed stable and 
showed no significant differences during the trial.
The increase in bicarbonate and urine pH values after drinking water D, 
showed the expected impact of water D on the acid-base metabolism. 
However, the sodium-bicarbonated mineral water did not lead to the 
expected decrease of bone resorption markers in this sample of healthy, 
young women. This could be explained by an insufficient study time 
(two weeks for each water), although in EMINOS-2, a significant effect 
on bone resorption was observed already after two weeks with calcium- 
and bicabonate-rich water, or by the relatively low calcium content of 
water B. There may also be a “calcium-effect”. Indeed, in EMINOS-3, 
water D was relatively low in calcium (103 mg/1), whereas in EMINOS- 
2, the water which led to the decrease of bone resorption markers had a 
very high calcium content (548 mg/1). Furthermore, in EMINOS-2, the 
two waters had very different PRAL (+9.2 mEq/1 for Water A and -11.2 
mEq/1 for Water B). In EMINOS-3, both waters are alkaline (-1.8 mEq/1 
for Water C and -40.8 mEq/1 for Water D) and this may therefore 
influence the results.
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7.6 Conclusion
In conclusion, the present study, EMINOS-2, has shown that a 
bicarbonate- and calcium-rich alkali mineral water decreased bone 
resorption more than a calcium-rich acidic mineral water, in healthy, pre­
menopausal subjects, on a calcium sufficient balanced diet. Further 
investigations need to be undertaken to study whether these positive 
effects are maintained in the long-term and whether they may have an 
influence on bone mineral density.
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8.CONCLUSION
8.1 Introductory comments
Nutrition has long been known to strongly influence acid-base balance in 
humans [163]. Intakes of potassium, magnesium, and fruit and 
vegetables have been associated with a more alkaline milieu in the 
human body and therefore, have a beneficial effect with regard to bone 
health [145].
Indeed, Western diets consumed by adults generate 50-100 mEq acid/d 
[234]. Therefore, healthy adults consuming such a diet are at risk of 
chronic low grade metabolic acidosis, which worsens with age due to a 
decline in kidney function [117].
In this context of nutritional acid-base balance, this PhD programme 
involved two key aspects:
The influence of dietary intake and acid load on bone health 
indices in healthy, elderly women.
The effect of an alkaline mineral water, rich in bicarbonate, 
compared with an acidic mineral water rich in calcium only, on 
bone markers, for young women with a normal calcium intake.
To the author’s best knowledge, the present studies are the first to give an 
insight into the acid-base balance in the elderly, Swiss population. Such 
data provides a valuable observation of the current estimated levels of
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dietary acidity in the elderly and the potential association with bone 
health indices.
Findings are summarised below, and concluding remarks are presented:
1) Development of a Swiss Food Frequency Questionnaire [241]
This research group developed and validated a Food Frequency 
Questionnaire (FFQ) for use in a frail, elderly Swiss population, to 
investigate the influence of nutritional factors on bone health. A detailed 
FFQ was developed, and cross-validated against a batch of 4 day Weighed 
Records (n=44). The short- (1 month, n=15) and long-term (12 months, 
n=14) reproducibility of the FFQ was also examined.
These results demonstrate that it is possible to develop FFQs for the 
elderly population and in doing so, collect data in large-scale 
epidemiological studies, with very good validity. This FFQ may now 
also be used for other dietary studies of the elderly in Switzerland.
2) Nutrient intake of the EVANIBUS population [252]
The validated FFQ was submitted to the 401 subjects to assess dietary 
intake. The FFQ showed a mean daily energy intake of 1544 kcal (+ 
447.7). Protein intake was 65.2 (+19.9)g/d; that is, 1.03 g/kg body
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weight per day. The mean daily intake for energy, fat, carbohydrate, 
calcium, magnesium, vitamin C, D and E, were all below the RNI. 
However, protein, phosphorus, potassium, iron and vitamin B6  were 
above the RNI. NEAP, using the PRAL equation, was also calculated for 
each subject.
It can be summarised that the nutrient intake in this cohort of 
independently-living, elderly, Swiss women was low, compared to the 
Swiss recommended nutrient intake. Vitamin D was found to be 
critically low compared to RNI and 50% of women were at risk of 
malnutrition, due to low-energy intake.
3) Association between NEAP estimates and bone ultrasound [275]
The association between Net Endogenous Acid Production (NEAP) 
estimates and bone ultra-sound results in the 401 EVANIBUS subjects 
were then assessed. No significant effects of acid loading were observed 
in the whole group, which led to a separate examination of women with a 
fracture history (n=256). Lower estimates of NEAP were significantly 
associated with higher BUA (r = -0.142, P<0.05).
The findings of the present study suggest that lower estimates of 
NEAP, (i.e. more alkaline diets), are significantly associated with
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higher indices of BUA measured by bone ultrasound in the very 
elderly population (mean age 80.6 years), in a sub-group of fractured 
women. High acid load may be an important, additional risk factor, 
which might be particularly relevant in frail patients with an already 
high risk of fracture.
4) Mineral water study [274]
The positive association between low estimates of dietary acid load and 
bone ultrasound in women >75y of age with a lifetime risk of fracture, 
encouraged an investigation into the effect of alkaline load in a younger 
population group. An assessment of the effect of drinking mineral-water 
on pre-menopausal women was undertaken. The consumption of mineral 
water may be an easy and affordable way of influencing positively the 
acid-base balance and consequently, having a more favourable impact on 
bone health parameters.
A comparison was made on the effect of an alkaline mineral water, rich 
in bicarbonate, with one of an acidic mineral water, rich in calcium only, 
on bone markers in young women with a normal calcium intake. This 
study compared;
Water A (per litre: 520 mg Ca, 291 mg H C O 3 - ,  1160 mg S O 4 ", Potential 
Renal Acid load (PRAL) + 9.2 mEq), with
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Water B (per litre: 547 mg Ca, 2172 mg HCO3 -, 9 mg SO4 ", PRAL -11.2 
mEq).
Urinary pH and bicarbonate excretion increased with water B, but not 
with water A. PTH (p=0.022) and S-CTX (p=0.023) decreased with 
water B, but not with water A.
In calcium sufficiency, the more acidic, calcium-rich water (A) had 
no effect on bone resorption, while the alkaline water rich in 
bicarbonate (B) led to a significant decrease of PTH and of S-CTX 
[274].
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8.2 Directions for future research work
Future work needs to be undertaken to assess whether certain fruits and 
vegetables have a more beneficial effect than other alkali-generating 
substances, namely mineral waters. Furthermore, some components 
found in several herbs, salad and vegetables have been shown to play a 
beneficial role in the rat model [276]; a role which is not mediated via 
acid-base regulation, but by pharmacologically active compounds, 
inherent in the aforementioned salad/vegetables and botanical foods. 
Indeed, certain phytonutrients and especially polyphenols, increase 
osteoblastic activity and decrease osteoclastic activity [277]. A recent 
study showed that onion consumption may have a beneficial effect on 
BMD in peri- and post-menopausal, white women aged 50 years or older 
[278].
Increasing the amount of fruit and vegetables in the Western population 
may be an additional prevention treatment for osteoporosis. However, 
increasing the daily fruit and vegetable consumption remains a difficult 
challenge, particularly given the current intakes, and the amounts that are 
required to have the purported osteogenic effects.
It should also be clearly borne in mind that there is an apparent mismatch 
between human genes and the modem diet, possibly explaining the 
negative effects of a diet low in potassium salts and poor bone status in 
older adults. Our pre-agricultural, hunter-gatherer ancestors consumed 
wild, animal-source foods and uncultivated plant-source foods, which 
consisted in a sodium-chloride poor, potassium-rich, bicarbonate-
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precursor, rich diet. This potassium to sodium chloride ratio has inverted 
with dietary shift, down through the ages. Consequently, in modem 
society, consumption of sodium chloride rich foods have increased at the 
expense of dietary plant foods [135].
Human genes are not adapted to this so-called “modem diet”, as the shift 
to this contemporary diet occurred too recently for the genetic 
determination to adjust [136-137]. It has been suggested that the dietary 
pattems responsible for low-grade metabolic acidosis, as well as low 
potassium intakes and high sodium chloride intakes, contribute to the 
pathogenesis of osteoporosis and other age-related disorders [138-139].
8.3 Concluding remarks
In the present thesis, the role of acid-base balance and bone health has 
been discussed. Dietary acid load appears to have a detrimental effect on 
bone health indices. Long-term studies would be of major interest to 
investigate the effect of an acidic diet and whether there is an influence 
on fracture risk, in both younger and older population groups.
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